-
Persistent negative symptoms in the EULAST cohort: impact on functional outcome. Schizophrenia (Heidelb). 2026 Mar 02. Giuliani L, Pezzella P, Giordano GM, Perrottelli A, Mucci A, Bucci P, Bitter I, Arango C, Luykx JJ, Díaz-Caneja CM, Ebdrup BH, Davidson M, Tiihonen J, Winter-van Rossum I, Galderisi S. PMID: 41766016.
-
Rethinking Schizophrenia: Optimizing Care Pathways in Europe from the First Episode of Psychosis to Long-Term Care. Eur Psychiatry. 2026 Feb 16; 1-27. Mohr P, Dom G, Falkai P, Arango C, Bitter I, Beezhold J, Boyer P, Catalan A, Chaumette B, Dollfus S, Duarte C, Fusar-Poli P, Gaebel W, Galderisi S, Howes O, Keri P, Meyer-Lindenberg A, Nordentoft M, Rybakowski J, Samochowiec J, Szulc A, Toczyski P, Vasco Santos J, Vita A, Quoidbach V. PMID: 41693469.
-
Do early intervention services for psychosis maintain their effects after transition to usual/modular care? A systematic review and meta-analysis. World Psychiatry. 2026 Feb; 25(1):95-104. Salazar de Pablo G, Almeida J, Camacho J, Suárez Campayo J, Catalan A, Pop M, Aymerich C, Rogdaki M, Robinson DG, Schooler N, McGuire P, Chang WC, Chen EY, Nordentoft M, Hjorthøj C, Albert N, Starzer M, Srihari V, Valencia M, Arango C, Kane J, Fusar-Poli P, Correll CU. PMID: 41536085; PMCID: PMC12805053.
-
Policy and public health implications for mental health after the COVID-19 pandemic. Lancet Psychiatry. 2026 Feb; 13(2):162-174. Nakimuli-Mpungu E, Arango C, Dandona R, Ford T, John A, Jordan A, Cherop R, Kola L, López-Jaramillo C, Schuster AM, Knapp M, Walbaum M, Opiepie K, Musoro F, White LA, Martsenkovskyi D, Michael BD, O'Connor R, MQ Mental Health Research and The Lancet Psychiatry Standing Commission on the COVID-19 Pandemic and, Jones PB. PMID: 41577421.
-
Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trial. EClinicalMedicine. 2026 Feb; 92:103760. Parellada M, San José Cáceres A, Delorme R, Moscoso A, Moreno C, Calvo R, Canal-Bedia R, Franco Martín MA, Charman T, Strydom A, Parr JR, Urbiola Merino E, Burdeus-Olavarrieta M, Hernández Jusdado P, Solis A, Lucas M, Sipos L, González Navarro P, Blázquez A, Lázaro L, Tomás A, Humeau E, Antoun S, Cooke J, Megalogeni M, Liang H, de-Vena-Díez VB, Leonard H, White N, Wang P, Walton-Bowen K, Winter-van Rossum I, Murphy D, Arango C. PMID: 41631164; PMCID: PMC12861286.
-
Brain Age in Conduct Disorder:: A Mega-Analysis of the ENIGMA Antisocial Behavior Working Group. bioRxiv. 2026 Jan 21. Dugré JR, Gao Y, Staginnus M, Marsh AA, Kypta-Vivanco A, Cubillo AI, Dietrich A, Bernhard A, Martinelli A, Dykstra AH, Smaragdi A, Sethi A, Bokde ALW, Franke B, Arango C, Boateng CPS, Stadler C, Freitag CM, Townsend CD, Monk CS, Hagan CC, Mitchell C, Dong D, Díaz DE, Brandeis D, Murphy D, Sukhodolsky DG, Sonuga-Barke EJS, Cardinale EM, Viding E, Kohls G, Schumann G, Cornwell H, Phillips H, Westerman HB, Chen H, Sagar-Ouriaghli I, Rogers JC, Buitelaar JK, Martinot JL, Glennon JC, Zhou J, Zhang J, Naaijen J, Castro-Fornieles J, Michalska KJ, Gonzalez-Madruga K, Ibrahim K, Sully K, Berluti K, Konrad K, Lamers K, Mycue LE, Passamonti L, Hyde LW, Oosterling M, Alonso MJP, Stevens MC, Craig M, Rosa-Justicia M, Ploe ML, Holz N, van der Wee NJA, Toschi N, Jabeen N, Raschle NM, Colins OF, Santosh P, Aggensteiner PM, Hoekstra PJ, Ming Q, Wu Q, Jackson RL, Ma R, Blair RJR, Vermeiren R, Pauli R, Roberts R, Burt SA, Bajaj S, Chester SC, Minosse S, Desrivieres S, Banaschewski T, Schulze UME, Chen X, Wang X, Sun X, Jiang Y, Jahanshad N, Thomopoulos SI, Ching CRK, Kang MJY, Thompson PM, Pine DS, Baskin-Sommers A, Cecil CAM, Aghajani M, Fairchild G, ENIGMA Antisocial Behavior Consortium, De Brito SA. PMID: 41648388; PMCID: PMC12871750.
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative Symptoms. Schizophr Bull. 2026 Jan 16; 52(1). Bugarski-Kirola D, Liu IY, Arango C, Marder SR. PMID: 40181715; PMCID: PMC12809779.
-
A European perspective on tardive dyskinesia. Eur Neuropsychopharmacol. 2026 Mar; 104:112740. Colosimo C, Jain R, Duma K, Kurzeja A, Arango C. PMID: 41421098.
-
Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study. Eur Neuropsychopharmacol. 2026 Mar; 104:112741. Agorastos A, Thompson T, Solmi M, Cortese S, Estradé A, Radua J, Dragioti E, Vancampfort D, Thygesen LC, Aschauer H, Schlögelhofer M, Aschauer E, Schneeberger A, Huber CG, Hasler G, Conus P, Do Cuénod KQ, von Känel R, Arrondo G, Fusar-Poli P, Gorwood P, Llorca PM, Krebs MO, Scanferla E, Kishimoto T, Rabbani G, Skonieczna-Zydecka K, Brambilla P, Favaro A, Takamiya A, Zoccante L, Colizzi M, Bourgin J, Kaminski K, Moghadasin M, Seedat S, Matthews E, Wells J, Vassilopoulou E, Gadelha A, Su KP, Kwon JS, Kim M, Lee T, Papsuev O, Manková D, Boscutti A, Gerunda C, Saccon D, Righi E, Monaco F, Croatto G, Cereda G, Demurtas J, Brondino N, Veronese N, Enrico P, Politi P, Ciappolino V, Pfennig A, Bechdolf A, Meyer-Lindenberg A, Kahl KG, Domschke K, Bauer M, Koutsouleris N, Winter SM, Borgwardt S, Bitter I, Balazs J, Czobor P, Unoka Z, Mavridis D, Tsamakis K, Bozikas VP, Tunvirachaisakul C, Maes M, Rungnirundorn T, Supasitthumrong T, Haque A, Brunoni AR, Costardi CG, Schuch FB, Polanczyk G, Luiz JM, Fonseca L, Aparicio LV, Valvassori SS, Nordentoft M, Vendsborg P, Hoffmann SH, Sehli J, Sartorius N, Heuss SC, Guinart D, Hamilton J, Kane J, Rubio J, Sand M, Koyanagi A, Solanes A, Andreu-Bernabeu A, Cáceres ASJ, Arango C, Díaz-Caneja CM, Hidalgo-Mazzei D, Vieta E, Gonzalez-Peñas J, Fortea L, Parellada M, Fullana MA, Verdolini N, Andrlíková E, Janku K, Millan MJ, Honciuc M, Moniuszko-Malinowska A, Loniewski I, Samochowiec J, Kiszkiel L, Marlicz M, Sowa P, Marlicz W, Spies G, Stubbs B, Firth J, Sullivan S, Darcin AE, Aksu H, Dilbaz N, Noyan O, Kitazawa M, Kurokawa S, Tazawa Y, Anselmi A, Cracco C, Machado AI, Estrade N, De Leo D, Curtis J, Berk M, Carvalho AF, Ward P, Teasdale S, Rosenbaum S, Marx W, Horodnic AV, Oprea L, Alexinschi O, Ifteni P, Turliuc S, Ciuhodaru T, Bolos A, Matei V, Nieman DH, Sommer I, van Os J, van Amelsvoort T, Sun CF, Guu TW, Jiao C, Zhang J, Fan J, Zou L, Yu X, Chi X, de Timary P, van Winkel R, Ng B, Pena E, Arellano R, Roman R, Sanchez T, Movina L, Morgado P, Brissos S, Aizberg O, Mosina A, Krinitski D, Mugisha J, Sadeghi-Bahmani D, Sheybani F, Sadeghi M, Hadi S, Brand S, Errazuriz A, Crossley N, Ristic DI, López-Jaramillo C, Efthymiou D, Kuttichira P, Kallivayalil RA, Javed A, Afridi MI, James B, Seb-Akahomen OJ, Fiedorowicz J, Daskalakis J, Yatham LN, Yang L, Okasha T, Dahdouh A, Tiihonen J, Shin JI, Lee J, Mhalla A, Gaha L, Brahim T, Altynbekov K, Negay N, Nurmagambetova S, Jamei YA, Weiser M, Correll CU. PMID: 41418519.
-
Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study. BJPsych Open. 2025 Dec 12; 12(1):e12. Demjaha A, Stahl D, Arango C, Glenthøj B, Rodriguez-Jimenez R, Díaz-Caneja CM, Baandrup L, Ebdrup B, Paz Garcia-Portlla M, Diaz-Marsa M, Winter-van Rossum I, Kahn R, Dazzan P, McGuire P. PMID: 41384453; PMCID: PMC12724093.
-
Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome. Res Sq. 2025 Dec 11. Latrèche C, Mancini V, Dvojakovska M, Kushan L, Mchangama F, Tair F, Cohen T, Spapens J, Reijn L, Díaz-Caneja CM, Acheampong H, Troch L, Vergaelen E, Vogels A, Swillen A, Vingerhoets C, Boot E, Arango C, Velders F, Fiksinski A, van Amelsvoort T, Gothelf D, Bearden CE, Chaumette B, Schneider M, Eliez S. PMID: 41510244; PMCID: PMC12776512.
-
Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach. Eur Neuropsychopharmacol. 2026 Jan; 102:28-38. Braak S, Oldehinkel M, Mennes M, Su T, Pijnenburg Y, Arango C, Ayuso-Mateos JL, van der Wee N, Dawson GR, Marston HM, Beckmann CF, Kas MJH, Penninx BWJH. PMID: 41308510.
-
Joint detection of risk for psychotic disorders or bipolar disorders in clinical practice in the UK: development and validation of a clinical prediction model. Lancet Psychiatry. 2026 Jan; 13(1):14-23. Arribas M, de Micheli A, Krakowski K, Stahl D, Correll CU, Young AH, Andreassen OA, Vieta E, Arango C, McGuire P, Oliver D, Fusar-Poli P. PMID: 41317739.
-
Individualized cortical thickness asymmetry in autism spectrum disorder and schizophrenia. Mol Psychiatry. 2025 Nov 23. Martín Echave M, Schnack HG, Díaz-Caneja CM, Pina-Camacho L, Janssen N, Gordaliza PM, Kho KH, Buimer EEL, van Haren NEM, Cahn W, Kahn RS, Hulshoff Pol HE, Arango C, Janssen J. PMID: 41276611.
-
Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes. Schizophrenia (Heidelb). 2025 Nov 13; 11(1):135. Lopez-Morinigo JD, Fraguas D, Diaz-Caneja CM, Galvañ J, Berger G, Leucht S, Rossum IW, Arango C, Moreno C. PMID: 41233335; PMCID: PMC12615624.
-
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative. Schizophrenia (Heidelb). 2025 Oct 15; 11(1):125. Bilgrami ZR, Castro E, Agurto C, Liebenthal E, Ennis M, Baker JT, Scott I, Colton BL, Cho KIK, Li L, Tamayo Z, Henecks M, Rahimi Eichi H, Henry T, Addington J, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Cornblatt BA, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui C, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Yassin W, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, McGorry PD, Kahn RS, Kane JM, Anticevic A, Bearden CE, Dwyer D, Billah T, Bouix S, Pasternak O, Shenton ME, Woods SW, Nelson B, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Cecchi GA, Corcoran CM, Wolff PM. PMID: 41093845; PMCID: PMC12528486.
-
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them. Am J Psychiatry. 2025 Nov 01; 182(11):969-983. Howes OD, Bukala BR, Chen EYH, Correll CU, Hasan A, Honer WG, Kane JM, Leucht S, Siafis S, Agid O, Akena D, Arango C, Atwoli L, Barnes TRE, Birnbaum ML, Bitter I, Breier A, Buchanan RW, Citrome L, Cotter DR, Crossley N, Davidson M, de Bartolomeis A, DeLisi LE, Dollfus S, Dursun SM, Ebdrup BH, Elkis H, Emsley R, Falkai P, Fernández-Egea E, Fleischhacker W, Freudenreich O, Gadelha A, Gaebel W, Graff-Guerrero A, Gridley A, Hallak JEC, Homan P, Kahn RS, Kaiser S, Kapi M, Kennedy JL, Kim E, Kinon BJ, Soo Kwon J, Lawrie SM, Lee J, Leweke FM, Li T, Libiger J, Marder SR, Melle I, Meltzer H, Mucci A, Naber D, Nakajima S, Nielsen J, O'Brien O, Ojagbemi A, Omlor W, Pantelis C, Peuskens J, Raedler TJ, Ran MS, Marques TR, Remington G, Rossell S, Rubio JM, Sachs G, Scott J, Si T, Siskind D, Siu CO, Sommer IE, Suzuki T, Takeuchi H, Tandon R, Taylor D, Teferra S, Thomas N, Tiihonen J, Uchida H, Ucok A, Umbricht D, Venkatasubramanian G, Wagner E, Walters JTR, Wang C, Weiser M, Wright C, Yu X, McCutcheon RA. PMID: 41058236.
-
Development and validation of a prognostic model and risk calculator for the estimation of bipolar-spectrum disorder risk in hospitalised adolescents with non-psychotic/non-bipolar mental disorders. Mol Psychiatry. 2026 Mar; 31(3):1333-1342. Salazar de Pablo G, Radua J, Frearson G, Young AH, Arango C, Kelleher I, Sharma A, Uhlhaas PJ, Solmi M, Fusar-Poli P, Guinart D, Correll CU. PMID: 41023422; PMCID: PMC12916283.
-
Premorbid functioning trajectories and the one-year course of cognitive performance in first-episode psychosis: a cluster analysis in PSYSCAN. Schizophr Res Cogn. 2026 Mar; 43:100391. Slot MIE, van Hell HH, Rossum IW, Gifford G, Dazzan P, Maat A, De Haan L, Crespo-Facorro B, Glenthøj BY, McDonald C, van Amelsvoort T, Arango C, Falkenberg I, Nelson B, Galderisi S, Weiser M, Sachs G, Maatz A, Kwon JS, PSYSCAN Consortium, McGuire P, Kahn RS. PMID: 41079561; PMCID: PMC12508902.
-
Polygenic and Polyenvironment Interplay in Schizophrenia-Spectrum Disorder and Affective Psychosis; the EUGEI First Episode Study. Schizophr Bull. 2025 Sep 08; 51(5):1254-1265. Rodriguez V, Alameda L, Aas M, Gayer-Anderson C, Trotta G, Spinazzola E, Quattrone D, Tripoli G, Jongsma HE, Stilo S, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, Bonora E, Jamain S, Selten JP, Velthorst E, de Haan L, Llorca PM, Arrojo M, Bobes J, Bernardo M, Arango C, Kirkbride J, Jones PB, Rutten BP, Richards A, Sham PC, O'Donovan M, Van Os J, Morgan C, Di Forti M, Murray RM, Vassos E. PMID: 39658350; PMCID: PMC12414556.
-
A population-based screening program provides insights into the characteristics and behaviors of individuals who self-refer for gambling disorder. Span J Psychiatry Ment Health. 2025 Sep 05. Ferre F, Roncero M, Szerman N, Basurte-Villamor I, Vega P, Nieves N, Civeira I, Arango C. PMID: 40915539.
-
Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences. Patient Prefer Adherence. 2025; 19:2647-2661. Arango C, Baeza I, García-Rizo C, Crespo-Facorro B, Lahera G, Vieta E, Becker F, Dwyer G, Bourke S, Gibson AEJ, Gabarda-Inat I, Alvarez-Baron E. PMID: 40901561; PMCID: PMC12400108.
-
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program. Schizophr Bull Open. 2025 Jan; 6(1):sgaf012. Addington J, Liu L, Chu M, Jungert K, Penzel N, Pasternak O, Farina E, Carrion RE, Corcoran CM, Mittal VA, Strauss GP, Yung AR, Alameda L, Arango C, Borders O, Bouix S, Breitborde NJK, Broome MR, Cadenhead KS, Castillo-Passi RI, Chen EYH, Choi J, Coleman MJ, Conus P, Diaz-Caneja CM, Ellman LM, Poli PF, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Kapur T, Kelly S, Kerr MJ, Keshavan MS, Kim M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Lewandowski KE, Mamah D, Marcy PJ, Mathalon DH, Mourgues C, Nordentoft M, Nunez AR, Pearlson GD, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Seitz-Holland J, Shah JL, Silverstein SM, Smesny S, Stone WS, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Zhang T, Addamo L, Buccilli K, Dwyer D, Todd S, Cho YT, Fontenau C, Tamayo Z, Bearden CE, Kane JM, McGorry PD, Kahn RS, Shenton ME, Woods SW, Accelerating Medicines Partnership® Schizophrenia Nelson Barnaby, Calkins ME. PMID: 40861307; PMCID: PMC12377803.
-
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program. Schizophr Bull Open. 2025 Jan; 6(1):sgaf013. Addington J, Shalev A, Liu L, Jahraus C, Chu M, Farina E, Fusar Poli P, Marcy PJ, Nunez AR, Calkins ME, Alameda L, Arango C, Borders O, Bouix S, Breitborde NJK, Broome MR, Cadenhead KS, Carrion RE, Castillo-Passi RI, Chen EYH, Choi J, Coleman MJ, Conus P, Corcoran CM, Diaz-Caneja CM, Ellman LM, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Kapur T, Kelly S, Kerr MJ, Keshavan MS, Kim M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Lewandowski KE, Mamah D, Mathalon DH, Mittal VA, Mourgues C, Nordentoft M, Pasternak O, Pearlson GD, Penzel N, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Seitz-Holland J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Yung AR, Zhang T, Addamo L, Buccilli K, Todd S, Dwyer D, Bearden CE, Kane JM, McGorry PD, Kahn RS, Shenton ME, Woods SW, Accelerating Medicines Partnership® Schizophrenia Nelson Barnaby. PMID: 40861306; PMCID: PMC12377801.
-
The need to prioritize "insomnia disorder" in public health agendas: "a wakeup call" position paper from European and Canadian experts in sleep and mental health. Sleep Med. 2025 Nov; 135:106763. Palagini L, Arango C, Bassetti CLA, Bastien C, Geoffroy PA, Elder G, Ellis J, Hedner J, Khullar A, Nobili L, Partinen M, Saletu M, Vieta E, Morin CM, Riemann D, Ferini Strambi L, Fiorillo A. PMID: 40886655.
-
Schizophrenia treatment preferences of psychiatrists versus guidelines: A European perspective. Eur Psychiatry. 2025 Aug 01; 68(1):e107. Rojnic Kuzman M, Nordentoft M, Raballo A, Mohr P, Fiorillo A, Dom G, Mihajlovic G, Jendricko T, Chumakov E, Barjaktarov S, Carpiniello B, Patarák M, Martin L, Dudek D, Samochowiec J, Taube M, Courtet P, Babic D, Racetovic G, Catthoor K, Arango C, Maruta N, Basar K, Vahip S, Szekeres G, Lien L, Popova A, Zhelev R, Jääskeläinen E, Delic M, Chkonia E, Chichai J, Telles-Correia D, Cosman DCM, Beezhold J, Falkai P. PMID: 40745910; PMCID: PMC12438985.
-
Human development, inequality, and their associations with brain structure across 29 countries. Eur Psychiatry. 2025 Jul 16; 68(1):e100. Medel V, Alliende LM, Bethlehem R, Seidlitz J, Ringlein G, Arango C, Arnatkeviciute A, Asmal L, Bellgrove M, Benegal V, Bernardo M, Billeke P, Bosch-Bayard J, Bressan R, Busatto G, Castro M, Chaim-Avancini T, Costanzi M, Czepielewski L, Dazzan P, de la Fuente-Sandoval C, Diaz-Caneja CM, Di Forti M, Diaz-Zuluaga AM, Du Plessis S, Duran F, Fittipaldi S, Fornito A, Freimer N, Gadelha A, Gama C, Garani R, Garcia-Rizo C, Gonzalez Campo C, Gonzalez-Valderrama A, Guinjoan S, Holla B, Ibañez A, Ivanovic D, Jackowski A, Leon-Ortiz P, Lochner C, Lopez-Jaramillo C, Luckhoff H, Massuda R, McGuire P, Miyata J, Mizrahi R, Murray R, Ozerdem A, Pan P, Parellada M, Phahladira L, Ramirez-Mahaluf JP, Reckziegel R, Marques TR, Reyes-Madrigal F, Roos A, Rosa P, Salum G, Scheffler F, Schumann G, Serpa M, Stein DJ, Tepper A, Tiego J, Ueno T, Undurraga J, Undurraga EA, Valdes-Sosa P, Valli I, Villarreal M, Winton-Brown TT, Yalin N, Zamorano F, Zanetti M, cVEDA, Winkler AM, Evans-Lacko S, Crossley NA. PMID: 40665512; PMCID: PMC12344469.
-
Extrapyramidal symptoms as early clinical predictors in first-episode schizophrenia and schizophreniform disorder: findings from the OPTiMiSE trial. Eur Neuropsychopharmacol. 2025 Sep; 98:35-45. Galvañ J, Suárez-Campayo J, Ayora M, Gil S, Winter-van Rossum I, Berger G, Leucht S, Kahn RS, Arango C, Díaz-Caneja CM. PMID: 40652754.
-
White matter microstructure of the cingulum bundle and the uncinate fasciculus in primary and secondary callous-unemotional traits. Eur Child Adolesc Psychiatry. 2025 Dec; 34(12):4035-4051. Schalk L, Sethi A, Saam MC, Flamarique I, Naaijen J, Dietrich A, Hoekstra PJ, Banaschewski T, Aggensteiner PM, Holz N, Baumeister S, Borràs R, Rosa-Justicia M, Santosh P, Sagar-Ouriaghli I, Arango C, José Penzol M, Brandeis D, Walitza S, Werhahn JE, Franke B, Glennon JC, Zwiers MP, Schulze UME, Castro-Fornieles J, Buitelaar JK, C Craig M. PMID: 40601040; PMCID: PMC12743073.
-
Linking prolonged childhood and adolescent loneliness to schizophrenia spectrum disorders: results from EU-GEI study. Br J Psychiatry. 2025 Jun 16; 1-9. Andreu-Bernabeu Á, González-Peñas J, Mora A, Bernardo M, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, Parellada M, Maric NP, Atbasoglu C, Üçok A, Alptekin K, Saka MC, Pries LK, O'Donovan M, van Os J, Rutten BPF, Delespaul P, Guloksuz S, Arango C, Díaz-Caneja CM. PMID: 40519115.
-
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures. Schizophrenia (Heidelb). 2025 Jun 06; 11(1):85. Mathalon DH, Nicholas S, Roach BJ, Billah T, Lavoie S, Whitford T, Hamilton HK, Addamo L, Anohkin A, Bekinschtein T, Belger A, Buccilli K, Cahill J, Carrión RE, Damiani S, Dzafic I, Ebdrup BH, Izyurov I, Jarcho J, Jenni R, Jo A, Kerins S, Lee C, Martin EA, Mayol-Troncoso R, Niznikiewicz MA, Parvaz M, Pogarell O, Prieto-Montalvo J, Rabin R, Roalf DR, Rogers J, Salisbury DF, Shaik R, Shankman S, Stevens MC, Suen YN, Swann NC, Tang X, Thompson JL, Tso I, Wenzel J, Zhou JH, Addington J, Alameda L, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Castillo-Passi RI, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Upthegrove R, Verma SK, Wang J, Wolf DH, Zhang T, Bouix S, Pasternak O, Cho KK, Coleman MJ, Dwyer D, Nunez A, Tamayo Z, Wood SJ, Kahn RS, Kane JM, McGorry PD, Bearden CE, Nelson B, Woods SW, Shenton ME, Accelerating Medicines Partnership® Schizophrenia Program, Light GA. PMID: 40480970; PMCID: PMC12144291.
-
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program. Schizophrenia (Heidelb). 2025 Jun 03; 11(1):83. Wigman JTW, Ching AE, Chung Y, Eichi HR, Lane E, Langholm C, Vaidyam A, Byun AJS, Haidar A, Hartmann J, Nunez A, Dwyer D, Nasarudin AA, Borders O, Scott I, Tamayo Z, Matneja P, Cho KI, Addington J, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Langbein K, Mamah D, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Yassin W, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Wolff P, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Rowland LM, D'Alfonso S, Pasternak O, Bouix S, McGorry PD, Kahn RS, Kane JM, Bearden CE, Woods SW, Shenton ME, Nelson B, Baker JT, Torous J. PMID: 40461469; PMCID: PMC12134270.
-
Cerebral cortical alterations in adolescent early-onset psychosis: a surface-based morphometry mega-analysis. medRxiv. 2025 May 28. Nerland S, Barth C, Jørgensen KN, Wortinger LA, Castro-Fornieles J, Díaz-Caneja CM, Janssen J, Arango C, Sugranyes G, Baeza I, Piras F, Banaj N, Piras F, Elia S, Vecchio D, Lundberg M, Bohman H, Rund BR, de la Serna E, Fortea A, Tamnes CK, Westlye LT, Smelror RE, Andreou D, Jönsson EG, Kempton MJ, Si S, Kyriakopoulos M, Bearden CE, Laulette K, Pascual-Diaz S, Fett AJ, Karlsgodt KH, Krabbendam L, Kochunov P, Thomopoulos SI, Jahanshad N, James A, Frangou S, Myhre AM, Steen NE, Andreassen OA, Thompson PM, Agartz I. PMID: 40492081; PMCID: PMC12148263.
-
Heterogeneity of morphometric similarity networks in health and schizophrenia. Schizophrenia (Heidelb). 2025 Apr 24; 11(1):70. Janssen J, Guil Gallego A, Díaz-Caneja CM, Gonzalez Lois N, Janssen N, González-Peñas J, Macias Gordaliza P, Buimer E, van Haren N, Arango C, Kahn R, Pol HEH, Schnack HG. PMID: 40274815; PMCID: PMC12022303.
-
Mental health status of the European population and its determinants: A cross-national comparison study. Eur Psychiatry. 2025 Apr 24; 68(1):e103. Lopez-Morinigo JD, Fiorillo A, Dom G, Arango C. PMID: 40268731; PMCID: PMC12344470.
-
PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample. Schizophrenia (Heidelb). 2025 Apr 17; 11(1):66. Tognin S, Vieira S, Oliver D, Cullen AE, Kempton MJ, Fusar-Poli P, Mechelli A, Dazzan P, Merritt K, Maat A, de Haan L, Lawrie SM, van Amelsvoort T, Arango C, Nelson B, Galderisi S, Bressan R, Kwon JS, Mizrahi R, PSYSCAN Consortium, Kahn RS, McGuire P. PMID: 40246889; PMCID: PMC12006469.
-
Comparison between accelerated and standard or sham rTMS in the treatment of depression: A systematic review. Neurosci Biobehav Rev. 2025 Jun; 173:106140. Lefaucheur JP, Colzi C, Hollander E, Pampaloni I, Van Ameringen M, Baeken C, Fusar-Poli P, Arango C, Fontenelle LF, Batail JM, Brunoni AR, Nicolini H, Haffen E, Soriano-Mas C, Rodriguez CI, Dell'Osso BM, Vieta E, Sauvaget A, Szekely D, Mayer-Linderberg A, Denys D, Stein DJ, Drapier D, Voon V, Pallanti S. PMID: 40252882.
-
Assessment of functional recovery in patients with schizophrenia, with a focus on early-phase disease: results from a Delphi consensus and narrative review. BMC Psychiatry. 2025 Apr 17; 25(1):398. Gorwood P, Yildirim M, Madera-McDonough J, Fagiolini A, Arango C, Correll CU, Arcà E, Barlassina A, Selveindran S, Sahota N, Kane JM. PMID: 40247199; PMCID: PMC12007312.
-
Responsiveness of European countries to the population mental health needs: A cross-national comparison study. Eur Psychiatry. 2025 Apr 14; 68(1):e102. Arango C, Fiorillo A, Dom G, Lopez-Morinigo JD. PMID: 40226991; PMCID: PMC12344467.
-
Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia (Heidelb). 2025 Apr 07; 11(1):57. Asgari-Targhi A, Yao B, Brown L, Garcia S, Nagendra A, Chin K, Billah T, Penzel N, John O, Prunier N, Veale S, Kotler E, Jacobs GR, Zhan M, Coleman MJ, Bouix S, Pasternak O, Cecci G, Baker JT, Mathalon DH, Kelly SM, Corcoran CM, Reichenberg A, Winter-van Rossum I, Kubicki M, Spark J, Dwyer D, Arango C, Fusar-Poli P, Calkins M, Shah JL, Mittal V, Thompson A, McGorry PD, Kahn RS, Kane JM, Bearden CE, Woods SW, Nelson B, Shenton ME, Staglin B, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Larrauri CA, Lewandowski KE, Kapur T. PMID: 40195300; PMCID: PMC11977264.
-
Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosis. Brain Behav Immun. 2025 Aug; 128:219-233. Aymerich C, Pedruzo B, Salazar de Pablo G, Labad J, McCutcheon R, Pillinger T, González-Torres MÁ, Sanchez-Gistau V, Oliver D, Alonso-Alconada D, Navalón P, Sugranyes G, Vieta E, Arango C, McGuire P, Fusar-Poli P, Catalan A. PMID: 40204113.
-
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia (Heidelb). 2025 Apr 03; 11(1):53. Penzel N, Polosecki P, Addington J, Arango C, Asgari-Targhi A, Billah T, Bouix S, Calkins ME, Campbell DE, Cannon TD, Castro E, Cho KIK, Coleman MJ, Corcoran CM, Dwyer D, Frangou S, Fusar-Poli P, Glynn RJ, Haidar A, Harms MP, Jacobs GR, Kambeitz J, Kapur T, Kelly SM, Koutsouleris N, Abhinandan KR, Kucukemiroglu S, Kwon JS, Lewandowski KE, Li QS, Mantua V, Mathalon DH, Mittal VA, Nicholas S, Pandina GJ, Perkins DO, Potter A, Reichenberg A, Reinen J, Sand MS, Seitz-Holland J, Shah JL, Srinivasan V, Srivastava A, Stone WS, Torous J, Vangel MG, Wang J, Wolff P, Yao B, Anticevic A, Wolf DH, Zhu H, Bearden CE, McGorry PD, Nelson B, Kane JM, Woods SW, Kahn RS, Shenton ME, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Cecchi G, Pasternak O. PMID: 40180950; PMCID: PMC11968818.
-
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia (Heidelb). 2025 Apr 03; 11(1):54. Addington J, Liu L, Braun A, Auther A, Calkins ME, Cornblatt BA, Corcoran CM, Fusar-Poli P, Kerr MJ, Mourgues-Codern CV, Nunez AR, Oliver D, Strauss GP, Walsh BC, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Carrion RE, Chen EYH, Choi J, Coleman MJ, Conus P, Diaz-Caneja CM, Dwyer D, Ellman LM, Faghankhani M, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui C, Jacobs GR, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Lewandowski KE, Mamah D, Marcy PJ, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Penzel N, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Thompson A, Thompson JL, Upthegrove R, Verma S, Wang J, Wastler HM, Wickham A, Rossum IW, Wolf DH, Bouix S, Pasternak O, Kahn RS, Bearden CE, Kane JM, McGorry PD, Buccilli K, Nelson B, Shenton ME, Woods SW, Accelerating Medicines Partnership® -Schizophrenia, Yung AR. PMID: 40180953; PMCID: PMC11968923.
-
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia (Heidelb). 2025 Apr 02; 11(1):52. Harms MP, Cho KK, Anticevic A, Bolo NR, Bouix S, Campbell D, Cannon TD, Cecchi G, Goncalves M, Haidar A, Hughes DE, Izyurov I, John O, Kapur T, Kim N, Kotler E, Kubicki M, Kuperman JM, Laulette K, Lindberg U, Markiewicz C, Ning L, Poldrack RA, Rathi Y, Romo PA, Tamayo Z, Wannan C, Wickham A, Yassin W, Zhou JH, Addington J, Alameda L, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma SK, Wang J, Wolf DH, Kahn RS, Kane JM, McGorry PD, Nelson B, Woods SW, Shenton ME, Wood SJ, Bearden CE, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Pasternak O. PMID: 40175382; PMCID: PMC11965426.
-
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample. Schizophrenia (Heidelb). 2025 Mar 24; 11(1):49. Allott K, Yassin W, Alameda L, Billah T, Borders O, Buccilli K, Carrión RE, Castillo-Passi RI, Cho KIK, Chin K, Coleman MJ, Colton BL, Corral S, Dwyer D, Gundersen KB, Gur RC, Hoftman GD, Jacobs GR, Kelly S, Lewandowski KE, Marcy PJ, Matneja P, McLaughlin D, Nunez AR, Parsa S, Penzel N, Ray S, Reinen JM, Ruparel K, Sand MS, Santorelli G, Seitz-Holland J, Spark J, Tamayo Z, Thompson A, Tod S, Wannan CMJ, Wickham A, Wood SJ, Zoupou E, Addington J, Anticevic A, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perkins DO, Perez J, Powers AR, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Strauss GP, Thompson JL, Upthegrove R, Verma SK, Wang J, Wolf DH, Pasternak O, Bouix S, McGorry PD, Kane JM, Kahn RS, Bearden CE, Shenton ME, Woods SW, Nelson B, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Stone WS. PMID: 40128256; PMCID: PMC11933323.
-
Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study. Eur Neuropsychopharmacol. 2025 Apr; 93:29-39. Vieta E, Ahmed N, Arango C, Cleare AJ, Demyttenaere K, Dold M, Ito T, Kambarov Y, Krüger S, Llorca PM, McIntyre RS, Sani G, von Holt C, Rive B. PMID: 39923271.
-
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors. Psychol Med. 2025 Feb 05; 55:e12. Ferraro L, Di Forti M, La Barbera D, La Cascia C, Morgan C, Tripoli G, Jongsma H, Seminerio F, Sartorio C, Sideli L, Tarricone I, Carloni AL, Szoke A, Pignon B, Bernardo M, de Haan L, Arango C, Velthorst E, Gayer-Anderson C, Kirkbride J, Rutten BPF, Lasalvia A, Tosato S, Del Ben CM, Menezes PR, Bobes J, Arrojo M, Tortelli A, Jones P, Selten JP, van Os J, WP2 EU-GEI Group, Murray R, Quattrone D, Vassos E. PMID: 39905765; PMCID: PMC11968123.
-
Disentangling the neural underpinnings of response inhibition in disruptive behavior and co-occurring ADHD. Eur Child Adolesc Psychiatry. 2025 Jul; 34(7):2253-2267. Saraçaydin G, van Rooij D, Kleine-Deters R, Messchendorp M, Naaijen J, Penzol MJ, Rosa M, Aggensteiner PM, Baumeister S, Holz N, Banaschewski T, Saam M, Schulze UME, Sethi A, Craig M, Castro-Fornieles J, Arango C, Walitza S, Werhahn J, Brandeis D, Franke B, Ruisch IH, Buitelaar JK, Dietrich A, Hoekstra PJ. PMID: 39825936; PMCID: PMC12334431.
-
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques. Can J Psychiatry. 2025 Mar; 70(3):182-193. Bond BW, Duric B, Spinazzola E, Trotta G, Chesney E, Li Z, Quattrone D, Tripoli G, Gayer-Anderson C, Rodriguez V, Ferraro L, La Cascia C, Tarricone I, Szöke A, Arango C, Bobes J, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Rutten BPF, de Haan L, Stilo S, Schürhoff F, Pignon B, Freeman TP, Vassos E, Murray RM, Austin-Zimmerman I, Di Forti M. PMID: 39810593; PMCID: PMC11733868.
-
Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel. Neurol Ther. 2025 Feb; 14(1):85-98. Bernardo M, Marsá MD, González-Pinto A, Carrasco MM, Sola VP, Sáiz PA, Vieta E, Torrens M, Arango C, Crespo-Facorro B. PMID: 39760831; PMCID: PMC11762036.
-
Prioritizing Brain Health in Youth: Bringing Neuroscience to Society and Informing Policy, Lessons Learnt from the European Brain Council Expert Meeting Held at the Federation of European Neuroscience Societies Forum 2024. Eur J Neurosci. 2025 Jan; 61(2):e16680. Dickson SL, Tracey I, Cirulli F, Kas MJH, Konradsson-Geuken Å, Rostasy K, Kestens E, Arango C, Mohr P, Balazs J, Simon J, Weemaes K, Boselli S, Hall J, Asakawa T, Quoidbach V. PMID: 39866081.
-
Triangulating the associations of different types of childhood adversity and first-episode psychosis with cortical thickness across brain regions. Psychol Med. 2024 Dec 16; 1-14. Fares-Otero NE, Verdolini N, Melero H, Andrés-Camazón P, Vilajosana E, Cavone V, García-Bueno B, Rapado-Castro M, Izquierdo A, Martín-Hernández D, Mola Cárdenes P, Leal I, Dompablo M, Ortiz-Tallo A, Martinez-Gras I, Muñoz-Sanjose A, Loeck de Lapuerta C, Rodriguez-Jimenez R, Díaz Marsá M, Bravo-Ortiz MF, Ibañez A, Baca-García E, Vieta E, Ayuso-Mateos JL, Malpica N, Arango C, Díaz-Caneja CM, Radua J. PMID: 39679545.
-
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies. Psychol Med. 2024 Dec 06; 1-13. Austin-Zimmerman I, Spinazzola E, Quattrone D, Wu-Choi B, Trotta G, Li Z, Johnson E, Richards AL, Freeman TP, Tripoli G, Gayer-Anderson C, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, Tosato S, Tarricone I, Berardi D, Bonora E, Seri M, D'Andrea G, Szöke A, Arango C, Bobes J, Sanjuán J, Santos JL, Arrojo M, Velthorst E, Bernardo M, Del-Ben CM, Rossi Menezes P, Selten JP, Jones PB, Kirkbride JB, Rutten BPF, Tortelli A, Llorca PM, de Haan L, Stilo S, La Barbera D, Lasalvia A, Schurnhoff F, Pignon B, van Os J, Lynskey M, Morgan C, EU-GEI WP2 Group, O' Donovan M, Lewis CM, Sham PC, Murray RM, Vassos E, Di Forti M. PMID: 39637925; PMCID: PMC11650186.
-
Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents. J Am Acad Child Adolesc Psychiatry. 2025 Apr; 64(4):499-519. Solmi M, Thompson T, Cortese S, Estradé A, Agorastos A, Radua J, Dragioti E, Vancampfort D, Thygesen LC, Aschauer H, Schlögelhofer M, Aschauer E, Schneeberger AA, Huber CG, Hasler G, Conus P, Do Cuénod KQ, von Känel R, Arrondo G, Fusar-Poli P, Gorwood P, Llorca PM, Krebs MO, Scanferla E, Kishimoto T, Rabbani G, Skonieczna-Zydecka K, Brambilla P, Favaro A, Takamiya A, Zoccante L, Colizzi M, Bourgin J, Kaminski K, Moghadasin M, Seedat S, Matthews E, Wells J, Vassilopoulou E, Gadelha A, Su KP, Kwon JS, Kim M, Lee TY, Papsuev O, Manková D, Boscutti A, Gerunda C, Saccon D, Righi E, Monaco F, Croatto G, Cereda G, Demurtas J, Brondino N, Veronese N, Enrico P, Politi P, Ciappolino V, Pfennig A, Bechdolf A, Meyer-Lindenberg A, Kahl KG, Domschke K, Bauer M, Koutsouleris N, Winter S, Borgwardt S, Bitter I, Balazs J, Czobor P, Unoka Z, Mavridis D, Tsamakis K, Bozikas VP, Tunvirachaisakul C, Maes M, Rungnirundorn T, Supasitthumrong T, Haque A, Brunoni AR, Costardi CG, Schuch FB, Polanczyk G, Luiz JM, Fonseca L, Aparicio LV, Valvassori SS, Nordentoft M, Vendsborg P, Hoffmann SH, Sehli J, Sartorius N, Heuss S, Guinart D, Hamilton J, Kane J, Rubio J, Sand M, Koyanagi A, Solanes A, Andreu-Bernabeu A, San José Cáceres A, Arango C, Díaz-Caneja CM, Hidalgo-Mazzei D, Vieta E, Gonzalez-Peñas J, Fortea L, Parellada M, Fullana MA, Verdolini N, Andrlíková E, Janku K, Millan MJ, Honciuc M, Moniuszko-Malinowska A, Loniewski I, Samochowiec J, Kiszkiel L, Marlicz M, Sowa P, Marlicz W, Spies G, Stubbs B, Firth J, Sullivan S, Darcin AE, Aksu H, Dilbaz N, Noyan O, Kitazawa M, Kurokawa S, Tazawa Y, Anselmi A, Cracco C, Machado AI, Estrade N, De Leo D, Curtis J, Berk M, Carvalho AF, Ward P, Teasdale S, Rosenbaum S, Marx W, Horodnic AV, Oprea L, Alexinschi O, Ifteni P, Turliuc S, Ciuhodaru T, Bolos A, Matei V, Nieman DH, Sommer I, van Os J, van Amelsvoort T, Sun CF, Guu TW, Jiao C, Zhang J, Fan J, Zou L, Yu X, Chi X, de Timary P, van Winkel R, Ng B, Pena E, Arellano R, Roman R, Sanchez T, Movina L, Morgado P, Brissos S, Aizberg O, Mosina A, Krinitski D, Mugisha J, Sadeghi-Bahmani D, Sheybani F, Sadeghi M, Hadi S, Brand S, Errazuriz A, Crossley N, Ristic DI, López-Jaramillo C, Efthymiou D, Kuttichira P, Kallivayalil RA, Javed A, Afridi MI, James B, Seb-Akahomen OJ, Fiedorowicz J, Daskalakis J, Yatham LN, Yang L, Okasha T, Dahdouh A, Tiihonen J, Shin JI, Lee J, Mhalla A, Gaha L, Brahim T, Altynbekov K, Negay N, Nurmagambetova S, Jamei YA, Weiser M, Correll CU. PMID: 39581373.
-
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings. Psychol Med. 2024 Nov 22; 1-11. Roldan L, Sánchez-Gutiérrez T, Fernández-Arias I, Rodríguez-Toscano E, López G, Merchán-Naranjo J, Calvo A, Rapado-Castro M, Parellada M, Moreno C, Ferraro L, La Barbera D, La Cascia C, Tripoli G, Di Forti M, Murray RM, Quattrone D, Morgan C, Gayer-Anderson C, Jones PB, Jongsma HE, Kirkbride JB, van Os J, García-Portilla P, Al-Halabí S, Bobes J, de Haan L, Bernardo M, Santos JL, Sanjuán J, Arrojo M, Szoke A, Rutten BP, Stilo SA, Tarricone I, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Selten JP, Tortelli A, Velthorst E, Del-Ben CM, Arango C, Díaz-Caneja CM. PMID: 39575607; PMCID: PMC11650177.
-
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study. Acta Psychiatr Scand. 2025 Apr; 151(4):506-520. D'Andrea G, Quattrone D, Tripoli G, Spinazzola E, Gayer-Anderson C, Jongsma HE, Sideli L, Stilo SA, La Cascia C, Ferraro L, La Barbera D, Tortelli A, Velthorst E, de Haan L, Llorca PM, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Kirkbride JB, Jones PB, Rutten BP, Schürhoff F, Szöke A, van Os J, Vassos E, Selten JP, Morgan C, Di Forti M, Tarricone I, Murray RM. PMID: 39483050; PMCID: PMC11884911.
-
The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part II: The future. Prog Neuropsychopharmacol Biol Psychiatry. 2025 Jan 10; 136:111176. Persico AM, Asta L, Chehbani F, Mirabelli S, Parlatini V, Cortese S, Arango C, Vitiello B. PMID: 39490514.
-
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis. Transl Psychiatry. 2024 10 26; 14(1):454. Alameda L, Rodriguez V, Di Forti M, Spinazzola E, Trotta G, Arango C, Arrojo M, Bernardo M, Bobes J, de Haan L, Del-Ben CM, Gayer-Anderson C, Sideli L, Jones PB, Kirkbride JB, La Cascia C, Tripoli G, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Llorca PM, Menezes PR, van Os J, Rutten BP, Santos JL, Sanjuán J, Selten JP, Szöke A, Tarricone I, Tortelli A, Velthorst E, Jongsma HE, Vassos E, Quattrone D, Murray RM, Aas M. PMID: 39461938; PMCID: PMC11513137.
-
Methylomic signature of current cannabis use in two first-episode psychosis cohorts. Mol Psychiatry. 2025 Apr; 30(4):1277-1286. Dempster EL, Wong CCY, Burrage J, Hannon E, Quattrone D, Trotta G, Rodriguez V, Alameda L, Spinazzola E, Tripoli G, Austin-Zimmerman I, Li Z, Gayer-Anderson C, Freeman TP, Johnson EC, Jongsma HE, Stilo S, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, D'Andrea G, Galatolo M, Tortelli A, Pompili M, Selten JP, de Haan L, Menezes PR, Del Ben CM, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Jones PB, Breen G, Mondelli V, Dazzan P, Iyegbe C, Vassos E, Morgan C, Mukherjee D, van Os J, Rutten B, O'Donovan MC, Sham P, Mill J, Murray R, Di Forti M. PMID: 39406996; PMCID: PMC11919776.
-
Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study. Eur Child Adolesc Psychiatry. 2025 May; 34(5):1603-1614. Arango C, Fegert JM, Picarel-Blanchot F, Marx U, Truffaut-Chalet L, Pénélaud PF, Buitelaar J, study investigators. PMID: 39390266; PMCID: PMC12122571.
-
Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN. Schizophrenia (Heidelb). 2024 Oct 07; 10(1):89. Slot MIE, Urquijo Castro MF, Winter-van Rossum I, van Hell HH, Dwyer D, Dazzan P, Maat A, De Haan L, Crespo-Facorro B, Glenthøj BY, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Weiser M, Sachs G, Kirschner M, PSYSCAN Consortium, Fleischhacker WW, McGuire P, Koutsouleris N, Kahn RS. PMID: 39375356; PMCID: PMC11458815.
-
The Mental Health Clinical Liaison Programme for Schools: developing a new approach in Child and Adolescent Mental Healthcare in Spain. Int Rev Psychiatry. 2025 May-Jun; 37(3-4):242-252. Camacho-Rubio J, Ulloa Á, Parellada M, Pina-Camacho L, M Díaz-Caneja C, Sevilla-Cermeño L, Arrieta M, Cerón B, Vidal J, Arango C. PMID: 40708418.
-
Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses. Eur Neuropsychopharmacol. 2025 Jan; 90:1-15. Solmi M, Thompson T, Cortese S, Estradé A, Agorastos A, Radua J, Dragioti E, Vancampfort D, Thygesen LC, Aschauer H, Schlögelhofer M, Aschauer E, Schneeberger A, Huber CG, Hasler G, Conus P, Cuénod KQD, von Känel R, Arrondo G, Fusar-Poli P, Gorwood P, Llorca PM, Krebs MO, Scanferla E, Kishimoto T, Rabbani G, Skonieczna-Zydecka K, Brambilla P, Favaro A, Takamiya A, Zoccante L, Colizzi M, Bourgin J, Kaminski K, Moghadasin M, Seedat S, Matthews E, Wells J, Vassilopoulou E, Gadelha A, Su KP, Kwon JS, Kim M, Lee TY, Papsuev O, Manková D, Boscutti A, Gerunda C, Saccon D, Righi E, Monaco F, Croatto G, Cereda G, Demurtas J, Brondino N, Veronese N, Enrico P, Politi P, Ciappolino V, Pfennig A, Bechdolf A, Meyer-Lindenberg A, Kahl KG, Domschke K, Bauer M, Koutsouleris N, Winter S, Borgwardt S, Bitter I, Balazs J, Czobor P, Unoka Z, Mavridis D, Tsamakis K, Bozikas VP, Tunvirachaisakul C, Maes M, Rungnirundorn T, Supasitthumrong T, Haque A, Brunoni AR, Costardi CG, Schuch FB, Polanczyk G, Luiz JM, Fonseca L, Aparicio LV, Valvassori SS, Nordentoft M, Vendsborg P, Hoffmann SH, Sehli J, Sartorius N, Heuss S, Guinart D, Hamilton J, Kane J, Rubio J, Sand M, Koyanagi A, Solanes A, Andreu-Bernabeu A, Cáceres ASJ, Arango C, Díaz-Caneja CM, Hidalgo-Mazzei D, Vieta E, Gonzalez-Peñas J, Fortea L, Parellada M, Fullana MA, Verdolini N, Andrlíková E, Janku K, Millan MJ, Honciuc M, Moniuszko-Malinowska A, Loniewski I, Samochowiec J, Kiszkiel L, Marlicz M, Sowa P, Marlicz W, Spies G, Stubbs B, Firth J, Sullivan S, Darcin AE, Aksu H, Dilbaz N, Noyan O, Kitazawa M, Kurokawa S, Tazawa Y, Anselmi A, Cracco C, Machado AI, Estrade N, De Leo D, Curtis J, Berk M, Carvalho AF, Ward P, Teasdale S, Rosenbaum S, Marx W, Horodnic AV, Oprea L, Alexinschi O, Ifteni P, Turliuc S, Ciuhodaru T, Bolos A, Matei V, Nieman DH, Sommer I, van Os J, van Amelsvoort T, Sun CF, Guu TW, Jiao C, Zhang J, Fan J, Zou L, Yu X, Chi X, de Timary P, van Winkel R, Ng B, Peña de León E, Arellano R, Roman R, Sanchez T, Movina L, Morgado P, Brissos S, Aizberg O, Mosina A, Krinitski D, Mugisha J, Sadeghi-Bahmani D, Sheybani F, Sadeghi M, Hadi S, Brand S, Errazuriz A, Crossley N, Ristic DI, López-Jaramillo C, Efthymiou D, Kuttichira P, Kallivayalil RA, Javed A, Afridi MI, James B, Seb-Akahomen OJ, Fiedorowicz J, Daskalakis J, Yatham LN, Yang L, Okasha T, Dahdouh A, Tiihonen J, Shin JI, Lee J, Mhalla A, Gaha L, Brahim T, Altynbekov K, Negay N, Nurmagambetova S, Jamei YA, Weiser M, Correll CU. PMID: 39341043.
-
The impact of sex in the effectiveness of functional remediation in bipolar disorder. Acta Psychiatr Scand. 2024 Dec; 150(6):543-561. Serra-Navarro M, Clougher D, Solé B, Sánchez-Moreno J, González-Pinto A, Jiménez E, Amann BL, Balanzá-Martínez V, Tabarés-Seisdedos R, Arango C, Accardo V, García-Portilla MP, Ibáñez Á, Crespo JM, Ayuso-Mateos JL, Amoretti S, Torrent C, Martínez-Aran A, Vieta E, CIBERSAM Functional Remediation Group. PMID: 39243167.
-
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study. Schizophr Bull. 2024 08 27; 50(5):1039-1049. Brink V, Andleeb H, Gayer-Anderson C, Arango C, Arrojo M, Berardi D, Bernardo M, Bobes J, Del-Ben CM, Ferraro L, de Haan L, La Barbera D, La Cascia C, Lasalvia A, Llorca PM, Menezes PR, Pignon B, Sanjuán J, Santos JL, Selten JP, Tarricone I, Tortelli A, Tripoli G, Velthorst E, Rutten BPF, van Os J, Quattrone D, Murray RM, Jones PB, Morgan C, Di Forti M, Jongsma HE, Kirkbride JB. PMID: 38788048; PMCID: PMC11349009.
-
New functional dissociations between prefrontal and parietal cortex during task switching: A combined fMRI and TMS study. Cortex. 2024 Oct; 179:91-102. Periáñez JA, Viejo-Sobera R, Lubrini G, Álvarez-Linera J, Rodríguez Toscano E, Moreno MD, Arango C, Redolar-Ripoll D, Muñoz Marrón E, Ríos-Lago M. PMID: 39163787.
-
Antipsychotic drugs in first-episode psychosis: a target trial emulation in the FEP-CAUSAL Collaboration. Am J Epidemiol. 2024 Aug 05; 193(8):1081-1087. Szmulewicz AG, Martínez-Alés G, Logan R, Ferrara M, Kelly C, Fredrikson D, Gago J, Conderino S, Díaz-Caneja CM, Galvañ J, Thorpe L, Srihari V, Yatham L, Sarpal DK, Shinn AK, Arango C, Öngür D, Hernán MA, Fep-Causal Collaboration OBOT. PMID: 38576166.
-
Large-scale analysis of structural brain asymmetries during neurodevelopment: Associations with age and sex in 4265 children and adolescents. Hum Brain Mapp. 2024 Aug 01; 45(11):e26754. Kurth F, Schijven D, van den Heuvel OA, Hoogman M, van Rooij D, Stein DJ, Buitelaar JK, Bölte S, Auzias G, Kushki A, Venkatasubramanian G, Rubia K, Bollmann S, Isaksson J, Jaspers-Fayer F, Marsh R, Batistuzzo MC, Arnold PD, Bressan RA, Stewart SE, Gruner P, Sorensen L, Pan PM, Silk TJ, Gur RC, Cubillo AI, Haavik J, O'Gorman Tuura RL, Hartman CA, Calvo R, McGrath J, Calderoni S, Jackowski A, Chantiluke KC, Satterthwaite TD, Busatto GF, Nigg JT, Gur RE, Retico A, Tosetti M, Gallagher L, Szeszko PR, Neufeld J, Ortiz AE, Ghisleni C, Lazaro L, Hoekstra PJ, Anagnostou E, Hoekstra L, Simpson B, Plessen JK, Deruelle C, Soreni N, James A, Narayanaswamy J, Reddy JY, Fitzgerald J, Bellgrove MA, Salum GA, Janssen J, Muratori F, Vila M, Giral MG, Ameis SH, Bosco P, Remnélius KL, Huyser C, Pariente JC, Jalbrzikowski M, Rosa PG, O'Hearn KM, Ehrlich S, Mollon J, Zugman A, Christakou A, Arango C, Fisher SE, Kong X, Franke B, Medland SE, Thomopoulos SI, Jahanshad N, Glahn DC, Thompson PM, Francks C, Luders E. PMID: 39046031; PMCID: PMC11267452.
-
Cortical structure and subcortical volumes in conduct disorder: a coordinated analysis of 15 international cohorts from the ENIGMA-Antisocial Behavior Working Group. Lancet Psychiatry. 2024 08; 11(8):620-632. Gao Y, Staginnus M, ENIGMA-Antisocial Behavior Working Group. PMID: 39025633.
-
Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies. Schizophr Bull. 2024 07 27; 50(4):771-783. Salazar de Pablo G, Guinart D, Armendariz A, Aymerich C, Catalan A, Alameda L, Rogdaki M, Martinez Baringo E, Soler-Vidal J, Oliver D, Rubio JM, Arango C, Kane JM, Fusar-Poli P, Correll CU. PMID: 38491933; PMCID: PMC11283197.
-
Cibersam: A change in the paradigm of mental health research in Spain. Span J Psychiatry Ment Health. 2025 Jan-Mar; 18(1):3-5. Arango C, Vieta E. PMID: 39047814.
-
Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI study. Schizophr Res. 2024 08; 270:339-348. Heuschen CBBCM, Bolhuis K, Zantvoord JB, Bockting CL, Denys DAJP, Lok A, Arango C, Arrojo M, Bernardo M, Bobes J, Del-Ben CM, Di Forti M, Gayer-Anderson C, Jones PB, Jongsma HE, Kirkbride JB, La Cascia C, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Murray RM, Quattrone D, Rutten BP, Sanjuán J, Selten JP, Szöke A, Tarricone I, Tortelli A, Velthorst E, de Haan L, Schirmbeck F. PMID: 38968805.
-
Verbal Learning and Memory Deficits across Neurological and Neuropsychiatric Disorders: Insights from an ENIGMA Mega Analysis. Brain Sci. 2024 Jun 29; 14(7). Kennedy E, Liebel SW, Lindsey HM, Vadlamani S, Lei PW, Adamson MM, Alda M, Alonso-Lana S, Anderson TJ, Arango C, Asarnow RF, Avram M, Ayesa-Arriola R, Babikian T, Banaj N, Bird LJ, Borgwardt S, Brodtmann A, Brosch K, Caeyenberghs K, Calhoun VD, Chiaravalloti ND, Cifu DX, Crespo-Facorro B, Dalrymple-Alford JC, Dams-O'Connor K, Dannlowski U, Darby D, Davenport N, DeLuca J, Diaz-Caneja CM, Disner SG, Dobryakova E, Ehrlich S, Esopenko C, Ferrarelli F, Frank LE, Franz CE, Fuentes-Claramonte P, Genova H, Giza CC, Goltermann J, Grotegerd D, Gruber M, Gutierrez-Zotes A, Ha M, Haavik J, Hinkin C, Hoskinson KR, Hubl D, Irimia A, Jansen A, Kaess M, Kang X, Kenney K, Kerková B, Khlif MS, Kim M, Kindler J, Kircher T, Knížková K, Kolskår KK, Krch D, Kremen WS, Kuhn T, Kumari V, Kwon J, Langella R, Laskowitz S, Lee J, Lengenfelder J, Liou-Johnson V, Lippa SM, Løvstad M, Lundervold AJ, Marotta C, Marquardt CA, Mattos P, Mayeli A, McDonald CR, Meinert S, Melzer TR, Merchán-Naranjo J, Michel C, Morey RA, Mwangi B, Myall DJ, Nenadic I, Newsome MR, Nunes A, O'Brien T, Oertel V, Ollinger J, Olsen A, Ortiz García de la Foz V, Ozmen M, Pardoe H, Parent M, Piras F, Piras F, Pomarol-Clotet E, Repple J, Richard G, Rodriguez J, Rodriguez M, Rootes-Murdy K, Rowland J, Ryan NP, Salvador R, Sanders AM, Schmidt A, Soares JC, Spalleta G, Španiel F, Sponheim SR, Stasenko A, Stein F, Straube B, Thames A, Thomas-Odenthal F, Thomopoulos SI, Tone EB, Torres I, Troyanskaya M, Turner JA, Ulrichsen KM, Umpierrez G, Vecchio D, Vilella E, Vivash L, Walker WC, Werden E, Westlye LT, Wild K, Wroblewski A, Wu MJ, Wylie GR, Yatham LN, Zunta-Soares GB, Thompson PM, Pugh MJ, Tate DF, Hillary FG, Wilde EA, Dennis EL. PMID: 39061410; PMCID: PMC11274572.
-
Shared vulnerability and sex-dependent polygenic burden in psychotic disorders. Eur Neuropsychopharmacol. 2024 Sep; 86:49-54. Mitjans M, Papiol S, Fatjó-Vilas M, González-Peñas J, Acosta-Díez M, Zafrilla-López M, Costas J, Arango C, Vilella E, Martorell L, Moltó MD, Bobes J, Crespo-Facorro B, González-Pinto A, Fañanás L, Rosa A, Arias B. PMID: 38941950.
-
Points to consider when initiating clinical investigations in autistic paediatric populations-A White Paper. Eur Neuropsychopharmacol. 2024 Sep; 86:35-42. Ham LM, Staunton H, Schulz JM, Tillmann J, Volz D, Murtagh L, Chatham C, O'Connor EC, Chamberlain S, Schoenenberger P, Pandina G, Wang P, Kas MJH, Arango C, Murphy D. PMID: 38917772.
-
Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer's disease patients. Eur Neuropsychopharmacol. 2024 Sep; 86:1-10. Braak S, Penninx BW, Su T, Pijnenburg Y, Nijland D, Campos AV, de la Torre-Luque A, Saris IMJ, Reus LM, Beckenstrom AC, Malik A, Dawson GR, Marston H, Alvarez-Linera J, Ayuso-Mateos JL, Arango C, van der Wee N, Kas MJ, Aghajani M. PMID: 38909542.
-
Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline. Neuropsychiatr Dis Treat. 2024; 20:1293-1307. Correll CU, Arango C, Fagiolini A, Giordano GM, Leucht S, Salazar de Pablo G. PMID: 38911102; PMCID: PMC11194005.
-
The lived experience of mental disorders in adolescents: a bottom-up review co-designed, co-conducted and co-written by experts by experience and academics. World Psychiatry. 2024 Jun; 23(2):191-208. Fusar-Poli P, Estradé A, Esposito CM, Rosfort R, Basadonne I, Mancini M, Stanghellini G, Otaiku J, Olanrele O, Allen L, Lamba M, Alaso C, Ieri J, Atieno M, Oluoch Y, Ireri P, Tembo E, Phiri IZ, Nkhoma D, Sichone N, Siadibbi C, Sundi PRIO, Ntokozo N, Fusar-Poli L, Floris V, Mensi MM, Borgatti R, Damiani S, Provenzani U, Brondino N, Bonoldi I, Radua J, Cooper K, Shin JI, Cortese S, Danese A, Bendall S, Arango C, Correll CU, Maj M. PMID: 38727047; PMCID: PMC11083893.
-
Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study. Psychiatry Res. 2024 Dec; 342:115972. Solmi M, Thompson T, Estradé A, Agorastos A, Radua J, Cortese S, Dragioti E, Vancampfort D, Thygesen LC, Aschauer H, Schlögelhofer M, Aschauer E, Schneeberger A, Huber CG, Hasler G, Conus P, Cuénod KQD, von Känel R, Arrondo G, Fusar-Poli P, Gorwood P, Llorca PM, Krebs MO, Scanferla E, Kishimoto T, Rabbani G, Skonieczna-Zydecka K, Brambilla P, Favaro A, Takamiya A, Zoccante L, Colizzi M, Bourgin J, Kaminski K, Moghadasin M, Seedat S, Matthews E, Wells J, Vassilopoulou E, Gadelha A, Su KP, Kwon JS, Kim M, Lee TY, Papsuev O, Manková D, Boscutti A, Gerunda C, Saccon D, Righi E, Monaco F, Croatto G, Cereda G, Demurtas J, Brondino N, Veronese N, Enrico P, Politi P, Ciappolino V, Pfennig A, Bechdolf A, Meyer-Lindenberg A, Kahl KG, Domschke K, Bauer M, Koutsouleris N, Winter S, Borgwardt S, Bitter I, Balazs J, Czobor P, Unoka Z, Mavridis D, Tsamakis K, Bozikas VP, Tunvirachaisakul C, Maes M, Rungnirundorn T, Supasitthumrong T, Haque A, Brunoni AR, Costardi CG, Schuch FB, Polanczyk G, Luiz JM, Fonseca L, Aparicio LV, Valvassori SS, Nordentoft M, Vendsborg P, Hoffmann SH, Sehli J, Sartorius N, Heuss S, Guinart D, Hamilton J, Kane J, Rubio J, Sand M, Koyanagi A, Solanes A, Andreu-Bernabeu A, Cáceres ASJ, Arango C, Díaz-Caneja CM, Hidalgo-Mazzei D, Vieta E, Gonzalez-Peñas J, Fortea L, Parellada M, Fullana MA, Verdolini N, Andrlíková E, Janku K, Millan MJ, Honciuc M, Moniuszko-Malinowska A, Loniewski I, Samochowiec J, Kiszkiel L, Marlicz M, Sowa P, Marlicz W, Spies G, Stubbs B, Firth J, Sullivan S, Darcin AE, Aksu H, Dilbaz N, Noyan O, Kitazawa M, Kurokawa S, Tazawa Y, Anselmi A, Cracco C, Machado AI, Estrade N, De Leo D, Curtis J, Berk M, Carvalho AF, Ward P, Teasdale S, Rosenbaum S, Marx W, Horodnic AV, Oprea L, Alexinschi O, Ifteni P, Turliuc S, Ciuhodaru T, Bolos A, Matei V, Nieman DH, Sommer I, van Os J, van Amelsvoort T, Sun CF, Guu TW, Jiao C, Zhang J, Fan J, Zou L, Yu X, Chi X, de Timary P, van Winkel R, Ng B, Peña de León E, Arellano R, Roman R, Sanchez T, Movina L, Morgado P, Brissos S, Aizberg O, Mosina A, Krinitski D, Mugisha J, Sadeghi-Bahmani D, Sheybani F, Sadeghi M, Hadi S, Brand S, Errazuriz A, Crossley N, Ristic DI, López-Jaramillo C, Efthymiou D, Kuttichira P, Kallivayalil RA, Javed A, Afridi MI, James B, Seb-Akahomen OJ, Fiedorowicz J, Daskalakis J, Yatham LN, Yang L, Okasha T, Dahdouh A, Tiihonen J, Shin JI, Lee J, Mhalla A, Gaha L, Brahim T, Altynbekov K, Negay N, Nurmagambetova S, Jamei YA, Weiser M, Correll CU. PMID: 39305825.
-
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe. Psychol Med. 2024 Aug; 54(11):2937-2946. Selten JP, Di Forti M, Quattrone D, Jones PB, Jongsma HE, Gayer-Anderson C, Szöke A, Llorca PM, Arango C, Bernardo M, Sanjuan J, Santos JL, Arrojo M, Tarricone I, Berardi D, Lasalvia A, Tosato S, la Cascia C, Velthorst E, van der Ven EMA, de Haan L, Rutten BP, van Os J, Kirkbride JB, Morgan CM, Murray RM, Termorshuizen F. PMID: 38721761.
-
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophr Bull. 2024 04 30; 50(3):496-512. Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, Cecci G, Chen EYH, Cho KIK, Choi J, Clark SR, Coleman MJ, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Dwyer D, Ebdrup BH, Ellman LM, Fusar-Poli P, Galindo L, Gaspar PA, Gerber C, Glenthøj LB, Glynn R, Harms MP, Horton LE, Kahn RS, Kambeitz J, Kambeitz-Ilankovic L, Kane JM, Kapur T, Keshavan MS, Kim SW, Koutsouleris N, Kubicki M, Kwon JS, Langbein K, Lewandowski KE, Light GA, Mamah D, Marcy PJ, Mathalon DH, McGorry PD, Mittal VA, Nordentoft M, Nunez A, Pasternak O, Pearlson GD, Perez J, Perkins DO, Powers AR, Roalf DR, Sabb FW, Schiffman J, Shah JL, Smesny S, Spark J, Stone WS, Strauss GP, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum IW, Wolf DH, Wolff P, Wood SJ, Yung AR, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión RE, Castro E, Cetin-Karayumak S, Mallar Chakravarty M, Cho YT, Cotter D, D'Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur RE, Gur RC, Hamilton HK, Hoftman GD, Jacobs GR, Jarcho J, Ji JL, Kohler CG, Lalousis PA, Lavoie S, Lepage M, Liebenthal E, Mervis J, Murty V, Nicholas SC, Ning L, Penzel N, Poldrack R, Polosecki P, Pratt DN, Rabin R, Rahimi Eichi H, Rathi Y, Reichenberg A, Reinen J, Rogers J, Ruiz-Yu B, Scott I, Seitz-Holland J, Srihari VH, Srivastava A, Thompson A, Turetsky BI, Walsh BC, Whitford T, Wigman JTW, Yao B, Yuen HP, Ahmed U, Byun AJS, Chung Y, Do K, Hendricks L, Huynh K, Jeffries C, Lane E, Langholm C, Lin E, Mantua V, Santorelli G, Ruparel K, Zoupou E, Adasme T, Addamo L, Adery L, Ali M, Auther A, Aversa S, Baek SH, Bates K, Bathery A, Bayer JMM, Beedham R, Bilgrami Z, Birch S, Bonoldi I, Borders O, Borgatti R, Brown L, Bruna A, Carrington H, Castillo-Passi RI, Chen J, Cheng N, Ching AE, Clifford C, Colton BL, Contreras P, Corral S, Damiani S, Done M, Estradé A, Etuka BA, Formica M, Furlan R, Geljic M, Germano C, Getachew R, Goncalves M, Haidar A, Hartmann J, Jo A, John O, Kerins S, Kerr M, Kesselring I, Kim H, Kim N, Kinney K, Krcmar M, Kotler E, Lafanechere M, Lee C, Llerena J, Markiewicz C, Matnejl P, Maturana A, Mavambu A, Mayol-Troncoso R, McDonnell A, McGowan A, McLaughlin D, McIlhenny R, McQueen B, Mebrahtu Y, Mensi M, Hui CLM, Suen YN, Wong SMY, Morrell N, Omar M, Partridge A, Phassouliotis C, Pichiecchio A, Politi P, Porter C, Provenzani U, Prunier N, Raj J, Ray S, Rayner V, Reyes M, Reynolds K, Rush S, Salinas C, Shetty J, Snowball C, Tod S, Turra-Fariña G, Valle D, Veale S, Whitson S, Wickham A, Youn S, Zamorano F, Zavaglia E, Zinberg J, Woods SW, Shenton ME. PMID: 38451304; PMCID: PMC11059785.
-
Effect of long-acting antipsychotic treatment on psychiatric hospitalization rate in early psychosis patients: a naturalistic study. Ther Adv Psychopharmacol. 2024; 14:20451253241243273. Sancho-Echeverria R, Aymerich C, Rodríguez-Sánchez JM, Gil P, Pedruzo B, González-Torres MÁ, Fusar-Poli P, Arango C, Catalan A. PMID: 38644940; PMCID: PMC11032064.
-
PsyCog: A computerised mini battery for assessing cognition in psychosis. Schizophr Res Cogn. 2024 Sep; 37:100310. Gifford G, Cullen AE, Vieira S, Searle A, McCutcheon RA, Modinos G, Stone WS, Hird E, Barnett J, van Hell HH, Catalan A, Millgate E, Taptiklis N, Cormack F, Slot ME, Dazzan P, Maat A, de Haan L, Facorro BC, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Bressan RA, Kwon JS, Weiser M, Mizrahi R, Sachs G, Kirschner M, Reichenberg A, PSYSCAN Consortium, Kahn R, McGuire P. PMID: 38572271; PMCID: PMC10987298.
-
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders. Biol Psychiatry. 2024 Sep 01; 96(5):376-389. González-Peñas J, Alloza C, Brouwer R, Díaz-Caneja CM, Costas J, González-Lois N, Gallego AG, de Hoyos L, Gurriarán X, Andreu-Bernabeu Á, Romero-García R, Fañanás L, Bobes J, González-Pinto A, Crespo-Facorro B, Martorell L, Arrojo M, Vilella E, Gutiérrez-Zotes A, Perez-Rando M, Moltó MD, CIBERSAM group, Buimer E, van Haren N, Cahn W, O'Donovan M, Kahn RS, Arango C, Pol HH, Janssen J, Schnack H. PMID: 38521159.
-
Identification and treatment of individuals with childhood-onset and early-onset schizophrenia. Eur Neuropsychopharmacol. 2024 May; 82:57-71. Correll CU, Arango C, Fagerlund B, Galderisi S, Kas MJ, Leucht S. PMID: 38492329.
-
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort. Schizophr Res. 2024 04; 266:237-248. Slot MIE, van Hell HH, Rossum IW, Dazzan P, Maat A, de Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Weiser M, Sachs G, Maatz A, Bressan RA, Kwon JS, Mizrahi R, PSYSCAN Consortium, McGuire P, Kahn RS. PMID: 38431986.
-
Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms. Mol Psychiatry. 2024 Jul; 29(7):2050-2058. Aranda S, Jiménez E, Canales-Rodríguez EJ, Verdolini N, Alonso S, Sepúlveda E, Julià A, Marsal S, Bobes J, Sáiz PA, García-Portilla P, Menchón JM, Crespo JM, González-Pinto A, Pérez V, Arango C, Sierra P, Sanjuán J, Pomarol-Clotet E, Vieta E, Vilella E. PMID: 38374360.
-
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study. Psychol Med. 2024 Jun; 54(8):1810-1823. D'Andrea G, Quattrone D, Malone K, Tripoli G, Trotta G, Spinazzola E, Gayer-Anderson C, Jongsma HE, Sideli L, Stilo SA, La Cascia C, Ferraro L, Lasalvia A, Tosato S, Tortelli A, Velthorst E, de Haan L, Llorca PM, Rossi Menezes P, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Kirkbride JB, Jones PB, Rutten BP, Van Os J, Selten JP, Vassos E, Schürhoff F, Szöke A, Pignon B, O'Donovan M, Richards A, Morgan C, Di Forti M, Tarricone I, Murray RM. PMID: 38288603.
-
A web-enabled, school-based intervention for bullying prevention (LINKlusive): a cluster randomised trial. EClinicalMedicine. 2024 Feb; 68:102427. Arango C, Martín-Babarro J, Abregú-Crespo R, Huete-Diego MÁ, Alvariño-Piqueras M, Serrano-Marugán I, Díaz-Caneja CM. PMID: 38318124; PMCID: PMC10839589.
-
Umbrella Review: Atlas of the Meta-Analytical Evidence of Early-Onset Psychosis. J Am Acad Child Adolesc Psychiatry. 2024 Jul; 63(7):684-697. Salazar de Pablo G, Rodriguez V, Besana F, Civardi SC, Arienti V, Maraña Garceo L, Andrés-Camazón P, Catalan A, Rogdaki M, Abbott C, Kyriakopoulos M, Fusar-Poli P, Correll CU, Arango C. PMID: 38280414.
-
Mapping gray and white matter volume abnormalities in early-onset psychosis: an ENIGMA multicenter voxel-based morphometry study. Mol Psychiatry. 2024 02; 29(2):496-504. Si S, Bi A, Yu Z, See C, Kelly S, Ambrogi S, Arango C, Baeza I, Banaj N, Berk M, Castro-Fornieles J, Crespo-Facorro B, Crouse JJ, Díaz-Caneja CM, Fett AK, Fortea A, Frangou S, Goldstein BI, Hickie IB, Janssen J, Kennedy KG, Krabbendam L, Kyriakopoulos M, MacIntosh BJ, Morgado P, Nerland S, Pascual-Diaz S, Picó-Pérez M, Piras F, Rund BR, de la Serna E, Spalletta G, Sugranyes G, Suo C, Tordesillas-Gutiérrez D, Vecchio D, Radua J, McGuire P, Thomopoulos SI, Jahanshad N, Thompson PM, Barth C, Agartz I, James A, Kempton MJ. PMID: 38195979; PMCID: PMC11116097.
-
Child and adolescent psychiatry in the context of disease prevention. Span J Psychiatry Ment Health. 2024 Jan-Mar; 17(1):1-2. Arango C. PMID: 38242591; PMCID: PMC10893780.
-
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis. Lancet Psychiatry. 2024 01; 11(1):36-46. Siafis S, Brandt L, McCutcheon RA, Gutwinski S, Schneider-Thoma J, Bighelli I, Kane JM, Arango C, Kahn RS, Fleischhacker WW, McGorry P, Carpenter WT, Falkai P, Hasan A, Marder SR, Schooler N, Engel RR, Honer WG, Buchanan RW, Davidson M, Weiser M, Priller J, Davis JM, Howes OD, Correll CU, Leucht S. PMID: 38043562.
-
Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis. Br J Psychiatry. 2023 07; 223(1):282-294. Salazar de Pablo G, Catalan A, Vaquerizo Serrano J, Pedruzo B, Alameda L, Sandroni V, Armendariz A, Rodriguez V, Arango C, Moreno C, Downs J, Abbott C, Shin JI, Solmi M, Fusar-Poli P, Correll CU. PMID: 37194556; PMCID: PMC10331322.
-
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery. BMC Psychiatry. 2023 06 21; 23(1):453. Arango C, Fagiolini A, Gorwood P, Kane JM, Diaz-Mendoza S, Sahota N, Correll CU. PMID: 37344763; PMCID: PMC10286361.
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study. Soc Psychiatry Psychiatr Epidemiol. 2023 Oct; 58(10):1573-1580. Sideli L, Aas M, Quattrone D, La Barbera D, La Cascia C, Ferraro L, Alameda L, Velthorst E, Trotta G, Tripoli G, Schimmenti A, Fontana A, Gayer-Anderson C, Stilo S, Seminerio F, Sartorio C, Marrazzo G, Lasalvia A, Tosato S, Tarricone I, Berardi D, D'Andrea G, EU-GEI WP2 Group, Arango C, Arrojo M, Bernardo M, Bobes J, Sanjuán J, Santos JL, Menezes PR, Del-Ben CM, Jongsma HE, Jones PB, Kirkbride JB, Llorca PM, Tortelli A, Pignon B, de Haan L, Selten JP, Van Os J, Rutten BP, Bentall R, Di Forti M, Murray RM, Morgan C, Fisher HL. PMID: 37335320; PMCID: PMC10460355.
-
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study. Psychol Med. 2023 11; 53(15):7375-7384. Trotta G, Rodriguez V, Quattrone D, Spinazzola E, Tripoli G, Gayer-Anderson C, Freeman TP, Jongsma HE, Sideli L, Aas M, Stilo SA, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, D'Andrea G, Tortelli A, Schürhoff F, Szöke A, Pignon B, Selten JP, Velthorst E, de Haan L, Llorca PM, Rossi Menezes P, Del Ben CM, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Kirkbride JB, Jones PB, Richards A, Rutten BP, Van Os J, Austin-Zimmerman I, Li Z, Morgan C, Sham PC, Vassos E, Wong C, Bentall R, Fisher HL, Murray RM, Alameda L, Di Forti M, EU-GEI WP2 Group. PMID: 38078747; PMCID: PMC10719680.
-
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study. Psychol Med. 2023 11; 53(15):7418-7427. Spinazzola E, Quattrone D, Rodriguez V, Trotta G, Alameda L, Tripoli G, Gayer-Anderson C, Freeman TP, Johnson EC, Jongsma HE, Stilo S, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, D'Andrea G, Galatolo M, Tortelli A, Tagliabue I, Turco M, Pompili M, Selten JP, de Haan L, Rossi Menezes P, Del Ben CM, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Kirkbride JB, Jones PB, O'Donovan M, Rutten BP, Van Os J, Morgan C, Sham PC, Austin-Zimmerman I, Li Z, Vassos E, EU-GEI WP2 Group, Murray RM, Di Forti M. PMID: 37129249; PMCID: PMC10719678.
-
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis-findings from the EU-GEI study. Mol Psychiatry. 2023 05; 28(5):2095-2106. Alameda L, Liu Z, Sham PC, Aas M, Trotta G, Rodriguez V, Di Forti M, Stilo SA, Kandaswamy R, Arango C, Arrojo M, Bernardo M, Bobes J, de Haan L, Del-Ben CM, Gayer-Anderson C, Sideli L, Jones PB, Jongsma HE, Kirkbride JB, La Cascia C, Lasalvia A, Tosato S, Llorca PM, Menezes PR, van Os J, Quattrone D, Rutten BP, Santos JL, Sanjuán J, Selten JP, Szöke A, Tarricone I, Tortelli A, Velthorst E, Morgan C, Dempster E, Hannon E, Burrage J, Dwir D, Arumuham A, Mill J, Murray RM, Wong CCY. PMID: 37062770.
-
Bridging Big Data: Procedures for Combining Non-equivalent Cognitive Measures from the ENIGMA Consortium. bioRxiv. 2023 Apr 07. Kennedy E, Vadlamani S, Lindsey HM, Lei PW, Jo-Pugh M, Adamson M, Alda M, Alonso-Lana S, Ambrogi S, Anderson TJ, Arango C, Asarnow RF, Avram M, Ayesa-Arriola R, Babikian T, Banaj N, Bird LJ, Borgwardt S, Brodtmann A, Brosch K, Caeyenberghs K, Calhoun VD, Chiaravalloti ND, Cifu DX, Crespo-Facorro B, Dalrymple-Alford JC, Dams-O'Connor K, Dannlowski U, Darby D, Davenport N, DeLuca J, Diaz-Caneja CM, Disner SG, Dobryakova E, Ehrlich S, Esopenko C, Ferrarelli F, Frank LE, Franz C, Fuentes-Claramonte P, Genova H, Giza CC, Goltermann J, Grotegerd D, Gruber M, Gutierrez-Zotes A, Ha M, Haavik J, Hinkin C, Hoskinson KR, Hubl D, Irimia A, Jansen A, Kaess M, Kang X, Kenney K, Kerková B, Khlif MS, Kim M, Kindler J, Kircher T, Knížková K, Kolskår KK, Krch D, Kremen WS, Kuhn T, Kumari V, Kwon JS, Langella R, Laskowitz S, Lee J, Lengenfelder J, Liebel SW, Liou-Johnson V, Lippa SM, Løvstad M, Lundervold A, Marotta C, Marquardt CA, Mattos P, Mayeli A, McDonald CR, Meinert S, Melzer TR, Merchán-Naranjo J, Michel C, Morey RA, Mwangi B, Myall DJ, Nenadic I, Newsome MR, Nunes A, O'Brien T, Oertel V, Ollinger J, Olsen A, de la Foz VOG, Ozmen M, Pardoe H, Parent M, Piras F, Piras F, Pomarol-Clotet E, Repple J, Richard G, Rodriguez J, Rodriguez M, Rootes-Murdy K, Rowland J, Ryan NP, Salvador R, Sanders AM, Schmidt A, Soares JC, Spalleta G, Španiel F, Stasenko A, Stein F, Straube B, Thames A, Thomas-Odenthal F, Thomopoulos SI, Tone E, Torres I, Troyanskaya M, Turner JA, Ulrichsen KM, Umpierrez G, Vilella E, Vivash L, Walker WC, Werden E, Westlye LT, Wild K, Wroblewski A, Wu MJ, Wylie GR, Yatham LN, Zunta-Soares GB, Thompson PM, Tate DF, Hillary FG, Dennis EL, Wilde EA. PMID: 36712107; PMCID: PMC9882238.
-
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium. Proc Natl Acad Sci U S A. 2023 04 04; 120(14):e2213880120. Schijven D, Postema MC, Fukunaga M, Matsumoto J, Miura K, de Zwarte SMC, van Haren NEM, Cahn W, Hulshoff Pol HE, Kahn RS, Ayesa-Arriola R, Ortiz-García de la Foz V, Tordesillas-Gutierrez D, Vázquez-Bourgon J, Crespo-Facorro B, Alnæs D, Dahl A, Westlye LT, Agartz I, Andreassen OA, Jönsson EG, Kochunov P, Bruggemann JM, Catts SV, Michie PT, Mowry BJ, Quidé Y, Rasser PE, Schall U, Scott RJ, Carr VJ, Green MJ, Henskens FA, Loughland CM, Pantelis C, Weickert CS, Weickert TW, de Haan L, Brosch K, Pfarr JK, Ringwald KG, Stein F, Jansen A, Kircher TTJ, Nenadic I, Krämer B, Gruber O, Satterthwaite TD, Bustillo J, Mathalon DH, Preda A, Calhoun VD, Ford JM, Potkin SG, Chen J, Tan Y, Wang Z, Xiang H, Fan F, Bernardoni F, Ehrlich S, Fuentes-Claramonte P, Garcia-Leon MA, Guerrero-Pedraza A, Salvador R, Sarró S, Pomarol-Clotet E, Ciullo V, Piras F, Vecchio D, Banaj N, Spalletta G, Michielse S, van Amelsvoort T, Dickie EW, Voineskos AN, Sim K, Ciufolini S, Dazzan P, Murray RM, Kim WS, Chung YC, Andreou C, Schmidt A, Borgwardt S, McIntosh AM, Whalley HC, Lawrie SM, du Plessis S, Luckhoff HK, Scheffler F, Emsley R, Grotegerd D, Lencer R, Dannlowski U, Edmond JT, Rootes-Murdy K, Stephen JM, Mayer AR, Antonucci LA, Fazio L, Pergola G, Bertolino A, Díaz-Caneja CM, Janssen J, Lois NG, Arango C, Tomyshev AS, Lebedeva I, Cervenka S, Sellgren CM, Georgiadis F, Kirschner M, Kaiser S, Hajek T, Skoch A, Spaniel F, Kim M, Kwak YB, Oh S, Kwon JS, James A, Bakker G, Knöchel C, Stäblein M, Oertel V, Uhlmann A, Howells FM, Stein DJ, Temmingh HS, Diaz-Zuluaga AM, Pineda-Zapata JA, López-Jaramillo C, Homan S, Ji E, Surbeck W, Homan P, Fisher SE, Franke B, Glahn DC, Gur RC, Hashimoto R, Jahanshad N, Luders E, Medland SE, Thompson PM, Turner JA, van Erp TGM, Francks C. PMID: 36976765; PMCID: PMC10083554.
-
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery. Res Sq. 2023 Mar 08. Arango C, Fagiolini A, Gorwood P, Kane JM, Diaz-Mendoza S, Sahota N, Correll CU. PMID: 36945577; PMCID: PMC10029086.
-
Pushing forward public mental health agenda and promotion of mental health. World Psychiatry. 2023 Feb; 22(1):170-171. Wasserman D, Arango C, Fiorillo A, Levin S, Peters AC, Rao GP, Sylla A, Sanchez-Villanueva T. PMID: 36640400; PMCID: PMC9840491.
-
In vivo white matter microstructure in adolescents with early-onset psychosis: a multi-site mega-analysis. Mol Psychiatry. 2023 03; 28(3):1159-1169. Barth C, Kelly S, Nerland S, Jahanshad N, Alloza C, Ambrogi S, Andreassen OA, Andreou D, Arango C, Baeza I, Banaj N, Bearden CE, Berk M, Bohman H, Castro-Fornieles J, Chye Y, Crespo-Facorro B, de la Serna E, Díaz-Caneja CM, Gurholt TP, Hegarty CE, James A, Janssen J, Johannessen C, Jönsson EG, Karlsgodt KH, Kochunov P, Lois NG, Lundberg M, Myhre AM, Pascual-Diaz S, Piras F, Smelror RE, Spalletta G, Stokkan TS, Sugranyes G, Suo C, Thomopoulos SI, Tordesillas-Gutiérrez D, Vecchio D, Wedervang-Resell K, Wortinger LA, Thompson PM, Agartz I. PMID: 36510004; PMCID: PMC10005938.
-
Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium. Mol Psychiatry. 2023 03; 28(3):1201-1209. Constantinides C, Han LKM, Alloza C, Antonucci LA, Arango C, Ayesa-Arriola R, Banaj N, Bertolino A, Borgwardt S, Bruggemann J, Bustillo J, Bykhovski O, Calhoun V, Carr V, Catts S, Chung YC, Crespo-Facorro B, Díaz-Caneja CM, Donohoe G, Plessis SD, Edmond J, Ehrlich S, Emsley R, Eyler LT, Fuentes-Claramonte P, Georgiadis F, Green M, Guerrero-Pedraza A, Ha M, Hahn T, Henskens FA, Holleran L, Homan S, Homan P, Jahanshad N, Janssen J, Ji E, Kaiser S, Kaleda V, Kim M, Kim WS, Kirschner M, Kochunov P, Kwak YB, Kwon JS, Lebedeva I, Liu J, Mitchie P, Michielse S, Mothersill D, Mowry B, de la Foz VO, Pantelis C, Pergola G, Piras F, Pomarol-Clotet E, Preda A, Quidé Y, Rasser PE, Rootes-Murdy K, Salvador R, Sangiuliano M, Sarró S, Schall U, Schmidt A, Scott RJ, Selvaggi P, Sim K, Skoch A, Spalletta G, Spaniel F, Thomopoulos SI, Tomecek D, Tomyshev AS, Tordesillas-Gutiérrez D, van Amelsvoort T, Vázquez-Bourgon J, Vecchio D, Voineskos A, Weickert CS, Weickert T, Thompson PM, Schmaal L, van Erp TGM, Turner J, Cole JH, ENIGMA Schizophrenia Consortium, Dima D, Walton E. PMID: 36494461; PMCID: PMC10005935.
-
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis. Schizophrenia (Heidelb). 2022 Nov 17; 8(1):100. Solanes A, Mezquida G, Janssen J, Amoretti S, Lobo A, González-Pinto A, Arango C, Vieta E, Castro-Fornieles J, Bergé D, Albacete A, Giné E, Parellada M, Bernardo M, PEPs group (collaborators), Pomarol-Clotet E, Radua J. PMID: 36396933; PMCID: PMC9672064.
-
Primary prevention in psychiatry is not science fiction. Eur Neuropsychopharmacol. 2022 12; 65:30-32. Arango C, Fusar-Poli P. PMID: 36228404.
-
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice. Eur Neuropsychopharmacol. 2022 10; 63:17-34. Fusar-Poli P, Manchia M, Koutsouleris N, Leslie D, Woopen C, Calkins ME, Dunn M, Tourneau CL, Mannikko M, Mollema T, Oliver D, Rietschel M, Reininghaus EZ, Squassina A, Valmaggia L, Kessing LV, Vieta E, Correll CU, Arango C, Andreassen OA, PSMD EBRA cluster (annex 1). PMID: 36041245.
-
Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence. Mol Psychiatry. 2023 01; 28(1):354-368. Solmi M, Croatto G, Piva G, Rosson S, Fusar-Poli P, Rubio JM, Carvalho AF, Vieta E, Arango C, DeTore NR, Eberlin ES, Mueser KT, Correll CU. PMID: 35999275.
-
The lived experience of psychosis: a bottom-up review co-written by experts by experience and academics. World Psychiatry. 2022 Jun; 21(2):168-188. Fusar-Poli P, Estradé A, Stanghellini G, Venables J, Onwumere J, Messas G, Gilardi L, Nelson B, Patel V, Bonoldi I, Aragona M, Cabrera A, Rico J, Hoque A, Otaiku J, Hunter N, Tamelini MG, Maschião LF, Puchivailo MC, Piedade VL, Kéri P, Kpodo L, Sunkel C, Bao J, Shiers D, Kuipers E, Arango C, Maj M. PMID: 35524616; PMCID: PMC9077608.
-
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI). Schizophr Bull. 2022 05 07; 48(3):575-589. Sideli L, Schimmenti A, La Barbera D, La Cascia C, Ferraro L, Aas M, Alameda L, Velthorst E, Fisher HL, Caretti V, Trotta G, Tripoli G, Quattrone D, Gayer-Anderson C, Seminerio F, Sartorio C, Marrazzo G, Lasalvia A, Tosato S, Tarricone I, Berardi D, D'Andrea G, Arango C, Arrojo M, Bernardo M, Bobes J, Sanjuán J, Santos JL, Menezes PR, Del-Ben CM, Jongsma HE, Jones PB, Kirkbride JB, Llorca PM, Tortelli A, Pignon B, de Haan L, Selten JP, Van Os J, Rutten BP, Di Forti M, Morgan C, Murray RM, EU-GEI WP2 Group. PMID: 35137235; PMCID: PMC9077421.
-
Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review. Mol Psychiatry. 2022 08; 27(8):3510-3519. Dragioti E, Radua J, Solmi M, Arango C, Oliver D, Cortese S, Jones PB, Il Shin J, Correll CU, Fusar-Poli P. PMID: 35484237; PMCID: PMC9708560.
-
Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models. Acta Psychiatr Scand. 2022 07; 146(1):21-35. Baandrup L, Allerup P, Nielsen MØ, Düring SW, Bojesen KB, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, Fleischhacker WW, Kahn RS, Glenthøj BY. PMID: 35417039; PMCID: PMC9325503.
-
Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response. J Am Acad Child Adolesc Psychiatry. 2023 02; 62(2):151-168. Salazar de Pablo G, Pastor Jordá C, Vaquerizo-Serrano J, Moreno C, Cabras A, Arango C, Hernández P, Veenstra-VanderWeele J, Simonoff E, Fusar-Poli P, Santosh P, Cortese S, Parellada M. PMID: 35470032.
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022 04; 604(7906):502-508. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, Koopmans F, Magnusson S, Richards AL, Sidorenko J, Wu Y, Zeng J, Grove J, Kim M, Li Z, Voloudakis G, Zhang W, Adams M, Agartz I, Atkinson EG, Agerbo E, Al Eissa M, Albus M, Alexander M, Alizadeh BZ, Alptekin K, Als TD, Amin F, Arolt V, Arrojo M, Athanasiu L, Azevedo MH, Bacanu SA, Bass NJ, Begemann M, Belliveau RA, Bene J, Benyamin B, Bergen SE, Blasi G, Bobes J, Bonassi S, Braun A, Bressan RA, Bromet EJ, Bruggeman R, Buckley PF, Buckner RL, Bybjerg-Grauholm J, Cahn W, Cairns MJ, Calkins ME, Carr VJ, Castle D, Catts SV, Chambert KD, Chan RCK, Chaumette B, Cheng W, Cheung EFC, Chong SA, Cohen D, Consoli A, Cordeiro Q, Costas J, Curtis C, Davidson M, Davis KL, de Haan L, Degenhardt F, DeLisi LE, Demontis D, Dickerson F, Dikeos D, Dinan T, Djurovic S, Duan J, Ducci G, Dudbridge F, Eriksson JG, Fañanás L, Faraone SV, Fiorentino A, Forstner A, Frank J, Freimer NB, Fromer M, Frustaci A, Gadelha A, Genovese G, Gershon ES, Giannitelli M, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, González Peñas J, González-Pinto A, Gopal S, Gratten J, Green MF, Greenwood TA, Guillin O, Gülöksüz S, Gur RE, Gur RC, Gutiérrez B, Hahn E, Hakonarson H, Haroutunian V, Hartmann AM, Harvey C, Hayward C, Henskens FA, Herms S, Hoffmann P, Howrigan DP, Ikeda M, Iyegbe C, Joa I, Julià A, Kähler AK, Kam-Thong T, Kamatani Y, Karachanak-Yankova S, Kebir O, Keller MC, Kelly BJ, Khrunin A, Kim SW, Klovins J, Kondratiev N, Konte B, Kraft J, Kubo M, Kucinskas V, Kucinskiene ZA, Kusumawardhani A, Kuzelova-Ptackova H, Landi S, Lazzeroni LC, Lee PH, Legge SE, Lehrer DS, Lencer R, Lerer B, Li M, Lieberman J, Light GA, Limborska S, Liu CM, Lönnqvist J, Loughland CM, Lubinski J, Luykx JJ, Lynham A, Macek M, Mackinnon A, Magnusson PKE, Maher BS, Maier W, Malaspina D, Mallet J, Marder SR, Marsal S, Martin AR, Martorell L, Mattheisen M, McCarley RW, McDonald C, McGrath JJ, Medeiros H, Meier S, Melegh B, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mitjans M, Molden E, Molina E, Molto MD, Mondelli V, Moreno C, Morley CP, Muntané G, Murphy KC, Myin-Germeys I, Nenadic I, Nestadt G, Nikitina-Zake L, Noto C, Nuechterlein KH, O'Brien NL, O'Neill FA, Oh SY, Olincy A, Ota VK, Pantelis C, Papadimitriou GN, Parellada M, Paunio T, Pellegrino R, Periyasamy S, Perkins DO, Pfuhlmann B, Pietiläinen O, Pimm J, Porteous D, Powell J, Quattrone D, Quested D, Radant AD, Rampino A, Rapaport MH, Rautanen A, Reichenberg A, Roe C, Roffman JL, Roth J, Rothermundt M, Rutten BPF, Saker-Delye S, Salomaa V, Sanjuan J, Santoro ML, Savitz A, Schall U, Scott RJ, Seidman LJ, Sharp SI, Shi J, Siever LJ, Sigurdsson E, Sim K, Skarabis N, Slominsky P, So HC, Sobell JL, Söderman E, Stain HJ, Steen NE, Steixner-Kumar AA, Stögmann E, Stone WS, Straub RE, Streit F, Strengman E, Stroup TS, Subramaniam M, Sugar CA, Suvisaari J, Svrakic DM, Swerdlow NR, Szatkiewicz JP, Ta TMT, Takahashi A, Terao C, Thibaut F, Toncheva D, Tooney PA, Torretta S, Tosato S, Tura GB, Turetsky BI, Üçok A, Vaaler A, van Amelsvoort T, van Winkel R, Veijola J, Waddington J, Walter H, Waterreus A, Webb BT, Weiser M, Williams NM, Witt SH, Wormley BK, Wu JQ, Xu Z, Yolken R, Zai CC, Zhou W, Zhu F, Zimprich F, Atbasoglu EC, Ayub M, Benner C, Bertolino A, Black DW, Bray NJ, Breen G, Buccola NG, et al. PMID: 35396580; PMCID: PMC9392466.
-
Genetic variants associated with longitudinal changes in brain structure across the lifespan. Nat Neurosci. 2022 04; 25(4):421-432. Brouwer RM, Klein M, Grasby KL, Schnack HG, Jahanshad N, Teeuw J, Thomopoulos SI, Sprooten E, Franz CE, Gogtay N, Kremen WS, Panizzon MS, Olde Loohuis LM, Whelan CD, Aghajani M, Alloza C, Alnæs D, Artiges E, Ayesa-Arriola R, Barker GJ, Bastin ME, Blok E, Bøen E, Breukelaar IA, Bright JK, Buimer EEL, Bülow R, Cannon DM, Ciufolini S, Crossley NA, Damatac CG, Dazzan P, de Mol CL, de Zwarte SMC, Desrivières S, Díaz-Caneja CM, Doan NT, Dohm K, Fröhner JH, Goltermann J, Grigis A, Grotegerd D, Han LKM, Harris MA, Hartman CA, Heany SJ, Heindel W, Heslenfeld DJ, Hohmann S, Ittermann B, Jansen PR, Janssen J, Jia T, Jiang J, Jockwitz C, Karali T, Keeser D, Koevoets MGJC, Lenroot RK, Malchow B, Mandl RCW, Medel V, Meinert S, Morgan CA, Mühleisen TW, Nabulsi L, Opel N, de la Foz VO, Overs BJ, Paillère Martinot ML, Redlich R, Marques TR, Repple J, Roberts G, Roshchupkin GV, Setiaman N, Shumskaya E, Stein F, Sudre G, Takahashi S, Thalamuthu A, Tordesillas-Gutiérrez D, van der Lugt A, van Haren NEM, Wardlaw JM, Wen W, Westeneng HJ, Wittfeld K, Zhu AH, Zugman A, Armstrong NJ, Bonfiglio G, Bralten J, Dalvie S, Davies G, Di Forti M, Ding L, Donohoe G, Forstner AJ, Gonzalez-Peñas J, Guimaraes JPOFT, Homuth G, Hottenga JJ, Knol MJ, Kwok JBJ, Le Hellard S, Mather KA, Milaneschi Y, Morris DW, Nöthen MM, Papiol S, Rietschel M, Santoro ML, Steen VM, Stein JL, Streit F, Tankard RM, Teumer A, van 't Ent D, van der Meer D, van Eijk KR, Vassos E, Vázquez-Bourgon J, Witt SH, IMAGEN Consortium, Adams HHH, Agartz I, Ames D, Amunts K, Andreassen OA, Arango C, Banaschewski T, Baune BT, Belangero SI, Bokde ALW, Boomsma DI, Bressan RA, Brodaty H, Buitelaar JK, Cahn W, Caspers S, Cichon S, Crespo-Facorro B, Cox SR, Dannlowski U, Elvsåshagen T, Espeseth T, Falkai PG, Fisher SE, Flor H, Fullerton JM, Garavan H, Gowland PA, Grabe HJ, Hahn T, Heinz A, Hillegers M, Hoare J, Hoekstra PJ, Ikram MA, Jackowski AP, Jansen A, Jönsson EG, Kahn RS, Kircher T, Korgaonkar MS, Krug A, Lemaitre H, Malt UF, Martinot JL, McDonald C, Mitchell PB, Muetzel RL, Murray RM, Nees F, Nenadic I, Oosterlaan J, Ophoff RA, Pan PM, Penninx BWJH, Poustka L, Sachdev PS, Salum GA, Schofield PR, Schumann G, Shaw P, Sim K, Smolka MN, Stein DJ, Trollor JN, van den Berg LH, Veldink JH, Walter H, Westlye LT, Whelan R, White T, Wright MJ, Medland SE, Franke B, Thompson PM, Hulshoff Pol HE. PMID: 35383335; PMCID: PMC10040206.
-
Cortical thinning over two years after first-episode psychosis depends on age of onset. Schizophrenia (Heidelb). 2022 03 11; 8(1):20. Pina-Camacho L, Martinez K, Diaz-Caneja CM, Mezquida G, Cuesta MJ, Moreno C, Amoretti S, González-Pinto A, Arango C, Vieta E, Castro-Fornieles J, Lobo A, Fraguas D, Bernardo M, Janssen J, Parellada M, PEPs Group. PMID: 35277520; PMCID: PMC8917180.
-
Virtual Ontogeny of Cortical Growth Preceding Mental Illness. Biol Psychiatry. 2022 08 15; 92(4):299-313. Patel Y, Shin J, Abé C, Agartz I, Alloza C, Alnæs D, Ambrogi S, Antonucci LA, Arango C, Arolt V, Auzias G, Ayesa-Arriola R, Banaj N, Banaschewski T, Bandeira C, Basgöze Z, Cupertino RB, Bau CHD, Bauer J, Baumeister S, Bernardoni F, Bertolino A, Bonnin CDM, Brandeis D, Brem S, Bruggemann J, Bülow R, Bustillo JR, Calderoni S, Calvo R, Canales-Rodríguez EJ, Cannon DM, Carmona S, Carr VJ, Catts SV, Chenji S, Chew QH, Coghill D, Connolly CG, Conzelmann A, Craven AR, Crespo-Facorro B, Cullen K, Dahl A, Dannlowski U, Davey CG, Deruelle C, Díaz-Caneja CM, Dohm K, Ehrlich S, Epstein J, Erwin-Grabner T, Eyler LT, Fedor J, Fitzgerald J, Foran W, Ford JM, Fortea L, Fuentes-Claramonte P, Fullerton J, Furlong L, Gallagher L, Gao B, Gao S, Goikolea JM, Gotlib I, Goya-Maldonado R, Grabe HJ, Green M, Grevet EH, Groenewold NA, Grotegerd D, Gruber O, Haavik J, Hahn T, Harrison BJ, Heindel W, Henskens F, Heslenfeld DJ, Hilland E, Hoekstra PJ, Hohmann S, Holz N, Howells FM, Ipser JC, Jahanshad N, Jakobi B, Jansen A, Janssen J, Jonassen R, Kaiser A, Kaleda V, Karantonis J, King JA, Kircher T, Kochunov P, Koopowitz SM, Landén M, Landrø NI, Lawrie S, Lebedeva I, Luna B, Lundervold AJ, MacMaster FP, Maglanoc LA, Mathalon DH, McDonald C, McIntosh A, Meinert S, Michie PT, Mitchell P, Moreno-Alcázar A, Mowry B, Muratori F, Nabulsi L, Nenadic I, O'Gorman Tuura R, Oosterlaan J, Overs B, Pantelis C, Parellada M, Pariente JC, Pauli P, Pergola G, Piarulli FM, Picon F, Piras F, Pomarol-Clotet E, Pretus C, Quidé Y, Radua J, Ramos-Quiroga JA, Rasser PE, Reif A, Retico A, Roberts G, Rossell S, Rovaris DL, Rubia K, Sacchet M, Salavert J, Salvador R, Sarró S, Sawa A, Schall U, Scott R, Selvaggi P, Silk T, Sim K, Skoch A, Spalletta G, Spaniel F, Stein DJ, Steinsträter O, Stolicyn A, Takayanagi Y, Tamm L, Tavares M, Teumer A, Thiel K, Thomopoulos SI, Tomecek D, Tomyshev AS, Tordesillas-Gutiérrez D, Tosetti M, Uhlmann A, Van Rheenen T, Vazquez-Bourgón J, Vernooij MW, Vieta E, Vilarroya O, Weickert C, Weickert T, Westlye LT, Whalley H, Willinger D, Winter A, Wittfeld K, Yang TT, Yoncheva Y, Zijlmans JL, Hoogman M, Franke B, van Rooij D, Buitelaar J, Ching CRK, Andreassen OA, Pozzi E, Veltman D, Schmaal L, van Erp TGM, Turner J, Castellanos FX, Pausova Z, Thompson P, Paus T. PMID: 35489875; PMCID: PMC11080987.
-
Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study. Psychol Med. 2023 Jun; 53(8):3471-3479. Demjaha A, Galderisi S, Glenthøj B, Arango C, Mucci A, Lawrence A, O'Daly O, Kempton M, Ciufolini S, Baandrup L, Ebdrup BH, Rodriguez-Jimenez R, Diaz-Marsa M, Díaz-Caneja CM, Winter van Rossum I, Kahn R, Dazzan P, McGuire P. PMID: 35197142; PMCID: PMC10277764.
-
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study. Psychol Med. 2023 Jun; 53(8):3396-3405. Rodriguez V, Alameda L, Quattrone D, Tripoli G, Gayer-Anderson C, Spinazzola E, Trotta G, Jongsma HE, Stilo S, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, Bonora E, Jamain S, Selten JP, Velthorst E, de Haan L, Llorca PM, Arrojo M, Bobes J, Bernardo M, Arango C, Kirkbride J, Jones PB, Rutten BP, Richards A, Sham PC, O'Donovan M, Van Os J, Morgan C, Di Forti M, Murray RM, Vassos E. PMID: 35076361; PMCID: PMC10277719.
-
Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022 03 08; 113:110463. de la Torre-Luque A, Viera-Campos A, Bilderbeck AC, Carreras MT, Vivancos J, Diaz-Caneja CM, Aghajani M, Saris IMJ, Raslescu A, Malik A, Clark J, Penninx BWJH, van der Wee N, Rossum IW, Sommer B, Marston H, Dawson GR, Kas MJ, Ayuso-Mateos JL, Arango C. PMID: 34718073.
-
Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas. World Psychiatry. 2021 Oct; 20(3):417-436. Arango C, Dragioti E, Solmi M, Cortese S, Domschke K, Murray RM, Jones PB, Uher R, Carvalho AF, Reichenberg A, Shin JI, Andreassen OA, Correll CU, Fusar-Poli P. PMID: 34505386; PMCID: PMC8429329.
-
Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: the EU-GEI study. Psychol Med. 2023 04; 53(5):1970-1978. Aas M, Alameda L, Di Forti M, Quattrone D, Dazzan P, Trotta A, Ferraro L, Rodriguez V, Vassos E, Sham P, Tripoli G, Cascia C, Barbera D, Tarricone I, Muratori R, Berardi D, Lasalvia A, Tosato S, Szöke A, Llorca PM, Arango C, Tortelli A, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Jongsma HE, Kirkbride JB, Rutten BPF, van Os J, Gayer-Anderson C, Murray RM, Morgan C. PMID: 37310339; PMCID: PMC10106300.
-
The impact of COVID-19 lockdown on child and adolescent mental health: systematic review. Eur Child Adolesc Psychiatry. 2023 Jul; 32(7):1151-1177. Panchal U, Salazar de Pablo G, Franco M, Moreno C, Parellada M, Arango C, Fusar-Poli P. PMID: 34406494; PMCID: PMC8371430.
-
Manifesto for an ECNP Neuromodulation Thematic Working Group (TWG): Non-invasive brain stimulation as a new Super-subspecialty. Eur Neuropsychopharmacol. 2021 11; 52:72-83. Pallanti S, Marras A, Dickson SL, Adan RA, Vieta E, Dell Osso B, Arango C, Fusar-Poli P, Soriano-Mas C, Carmi L, Meyer Lindenberg A, Zohar J. PMID: 34348181.
-
Primary prevention of depression: An umbrella review of controlled interventions. J Affect Disord. 2021 11 01; 294:957-970. Salazar de Pablo G, Solmi M, Vaquerizo-Serrano J, Radua J, Passina A, Mosillo P, Correll CU, Borgwardt S, Galderisi S, Bechdolf A, Pfennig A, Bauer M, Kessing LV, van Amelsvoort T, Nieman DH, Domschke K, Krebs MO, Sand M, Vieta E, McGuire P, Arango C, Shin JI, Fusar-Poli P. PMID: 34375224.
-
Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis. EClinicalMedicine. 2021 Jun; 36:100909. Salazar de Pablo G, Besana F, Arienti V, Catalan A, Vaquerizo-Serrano J, Cabras A, Pereira J, Soardo L, Coronelli F, Kaur S, da Silva J, Oliver D, Petros N, Moreno C, Gonzalez-Pinto A, Díaz-Caneja CM, Shin JI, Politi P, Solmi M, Borgatti R, Mensi MM, Arango C, Correll CU, McGuire P, Fusar-Poli P. PMID: 34189444; PMCID: PMC8219991.
-
Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry. 2021 Jun; 20(2):200-221. Fusar-Poli P, Correll CU, Arango C, Berk M, Patel V, Ioannidis JPA. PMID: 34002494; PMCID: PMC8129854.
-
Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis. Harv Rev Psychiatry. 2021 May-Jun 01; 29(3):196-215. Salazar de Pablo G, De Micheli A, Solmi M, Oliver D, Catalan A, Verdino V, Di Maggio L, Bonoldi I, Radua J, Baccaredda Boy O, Provenzani U, Ruzzi F, Calorio F, Nosari G, Di Marco B, Famularo I, Montealegre I, Signorini L, Molteni S, Filosi E, Mensi M, Balottin U, Politi P, Shin JI, Correll CU, Arango C, Fusar-Poli P. PMID: 33979106.
-
Drug development in ASD, an ISCTM-ECNP joint adventure. Eur Neuropsychopharmacol. 2021 07; 48:1-2. Arango C. PMID: 33832786.
-
A normative chart for cognitive development in a genetically selected population. Neuropsychopharmacology. 2022 06; 47(7):1379-1386. Fiksinski AM, Bearden CE, Bassett AS, Kahn RS, Zinkstok JR, Hooper SR, Tempelaar W, McDonald-McGinn D, Swillen A, Emanuel B, Morrow B, Gur R, Chow E, van den Bree M, Vermeesch J, Warren S, Owen M, van Amelsvoort T, Eliez S, Gothelf D, Arango C, Kates W, Simon T, Murphy K, Repetto G, Suner DH, Vicari S, Cubells J, Armando M, Philip N, Campbell L, Garcia-Minaur S, Schneider M, Shashi V, 22q11DS International Consortium on Brain and Behavior, Vorstman J, Breetvelt EJ. PMID: 33782512; PMCID: PMC9117666.
-
Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study. Schizophr Bull. 2021 03 16; 47(2):444-455. Dazzan P, Lawrence AJ, Reinders AATS, Egerton A, van Haren NEM, Merritt K, Barker GJ, Perez-Iglesias R, Sendt KV, Demjaha A, Nam KW, Sommer IE, Pantelis C, Wolfgang Fleischhacker W, van Rossum IW, Galderisi S, Mucci A, Drake R, Lewis S, Weiser M, Martinez Diaz-Caneja CM, Janssen J, Diaz-Marsa M, Rodríguez-Jimenez R, Arango C, Baandrup L, Broberg B, Rostrup E, Ebdrup BH, Glenthøj B, Kahn RS, McGuire P, OPTiMiSE study group. PMID: 33057670; PMCID: PMC7965060.
-
Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs. Hum Brain Mapp. 2022 01; 43(1):300-328. Sønderby IE, Ching CRK, Thomopoulos SI, van der Meer D, Sun D, Villalon-Reina JE, Agartz I, Amunts K, Arango C, Armstrong NJ, Ayesa-Arriola R, Bakker G, Bassett AS, Boomsma DI, Bülow R, Butcher NJ, Calhoun VD, Caspers S, Chow EWC, Cichon S, Ciufolini S, Craig MC, Crespo-Facorro B, Cunningham AC, Dale AM, Dazzan P, de Zubicaray GI, Djurovic S, Doherty JL, Donohoe G, Draganski B, Durdle CA, Ehrlich S, Emanuel BS, Espeseth T, Fisher SE, Ge T, Glahn DC, Grabe HJ, Gur RE, Gutman BA, Haavik J, Håberg AK, Hansen LA, Hashimoto R, Hibar DP, Holmes AJ, Hottenga JJ, Hulshoff Pol HE, Jalbrzikowski M, Knowles EEM, Kushan L, Linden DEJ, Liu J, Lundervold AJ, Martin-Brevet S, Martínez K, Mather KA, Mathias SR, McDonald-McGinn DM, McRae AF, Medland SE, Moberget T, Modenato C, Monereo Sánchez J, Moreau CA, Mühleisen TW, Paus T, Pausova Z, Prieto C, Ragothaman A, Reinbold CS, Reis Marques T, Repetto GM, Reymond A, Roalf DR, Rodriguez-Herreros B, Rucker JJ, Sachdev PS, Schmitt JE, Schofield PR, Silva AI, Stefansson H, Stein DJ, Tamnes CK, Tordesillas-Gutiérrez D, Ulfarsson MO, Vajdi A, van 't Ent D, van den Bree MBM, Vassos E, Vázquez-Bourgon J, Vila-Rodriguez F, Walters GB, Wen W, Westlye LT, Wittfeld K, Zackai EH, Stefánsson K, Jacquemont S, Thompson PM, Bearden CE, Andreassen OA, ENIGMA-CNV Working Group, ENIGMA 22q11.2 Deletion Syndrome Working Group. PMID: 33615640; PMCID: PMC8675420.
-
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings. Mol Psychiatry. 2021 08; 26(8):4529-4543. Velthorst E, Mollon J, Murray RM, de Haan L, Germeys IM, Glahn DC, Arango C, van der Ven E, Di Forti M, Bernardo M, Guloksuz S, Delespaul P, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Santos JL, Jiménez-López E, Sanjuan J, Aguilar EJ, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Atbasoglu C, Saka MC, Üçok A, Alptekin K, Akdede B, Binbay T, Altinyazar V, Ulas H, Yalinçetin B, Gümüs-Akay G, Beyaz BC, Soygür H, Cankurtaran ES, Kaymak SU, Maric NP, Mihaljevic MM, Petrovic SA, Mirjanic T, Del-Ben CM, Ferraro L, Gayer-Anderson C, Jones PB, Jongsma HE, Kirkbride JB, La Cascia C, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Morgan C, Quattrone D, Menchetti M, Selten JP, Szöke A, Tarricone I, Tortelli A, McGuire P, Valmaggia L, Kempton MJ, van der Gaag M, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Nelson B, McGorry P, Pantelis C, Krebs MO, Ruhrmann S, Sachs G, Rutten BPF, van Os J, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, Bruggeman R, van Beveren NJ, Luykx JJ, Cahn W, Simons CJP, Kahn RS, Schirmbeck F, van Winkel R, EU-GEI High Risk Study, Reichenberg A. PMID: 33414498.
-
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. JAMA Psychiatry. 2021 Jan 01; 78(1):47-63. Writing Committee for the Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Bipolar Disorder, Major Depressive Disorder, Obsessive-Compulsive Disorder, and Schizophrenia ENIGMA Working Groups, Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abé C, Anticevic A, Alda M, Aleman A, Alloza C, Alonso-Lana S, Ameis SH, Anagnostou E, McIntosh AA, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Ayesa-Arriola R, Bakker G, Banaj N, Banaschewski T, Bandeira CE, Baranov A, Bargalló N, Bau CHD, Baumeister S, Baune BT, Bellgrove MA, Benedetti F, Bertolino A, Boedhoe PSW, Boks M, Bollettini I, Del Mar Bonnin C, Borgers T, Borgwardt S, Brandeis D, Brennan BP, Bruggemann JM, Bülow R, Busatto GF, Calderoni S, Calhoun VD, Calvo R, Canales-Rodríguez EJ, Cannon DM, Carr VJ, Cascella N, Cercignani M, Chaim-Avancini TM, Christakou A, Coghill D, Conzelmann A, Crespo-Facorro B, Cubillo AI, Cullen KR, Cupertino RB, Daly E, Dannlowski U, Davey CG, Denys D, Deruelle C, Di Giorgio A, Dickie EW, Dima D, Dohm K, Ehrlich S, Ely BA, Erwin-Grabner T, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Fatjó-Vilas M, Fedor JM, Fitzgerald KD, Ford JM, Frodl T, Fu CHY, Fullerton JM, Gabel MC, Glahn DC, Roberts G, Gogberashvili T, Goikolea JM, Gotlib IH, Goya-Maldonado R, Grabe HJ, Green MJ, Grevet EH, Groenewold NA, Grotegerd D, Gruber O, Gruner P, Guerrero-Pedraza A, Gur RE, Gur RC, Haar S, Haarman BCM, Haavik J, Hahn T, Hajek T, Harrison BJ, Harrison NA, Hartman CA, Whalley HC, Heslenfeld DJ, Hibar DP, Hilland E, Hirano Y, Ho TC, Hoekstra PJ, Hoekstra L, Hohmann S, Hong LE, Höschl C, Høvik MF, Howells FM, Nenadic I, Jalbrzikowski M, James AC, Janssen J, Jaspers-Fayer F, Xu J, Jonassen R, Karkashadze G, King JA, Kircher T, Kirschner M, Koch K, Kochunov P, Kohls G, Konrad K, Krämer B, Krug A, Kuntsi J, Kwon JS, Landén M, Landrø NI, Lazaro L, Lebedeva IS, Leehr EJ, Lera-Miguel S, Lesch KP, Lochner C, Louza MR, Luna B, Lundervold AJ, MacMaster FP, Maglanoc LA, Malpas CB, Portella MJ, Marsh R, Martyn FM, Mataix-Cols D, Mathalon DH, McCarthy H, McDonald C, McPhilemy G, Meinert S, Menchón JM, Minuzzi L, Mitchell PB, Moreno C, Morgado P, Muratori F, Murphy CM, Murphy D, Mwangi B, Nabulsi L, Nakagawa A, Nakamae T, Namazova L, Narayanaswamy J, Jahanshad N, Nguyen DD, Nicolau R, O'Gorman Tuura RL, O'Hearn K, Oosterlaan J, Opel N, Ophoff RA, Oranje B, García de la Foz VO, Overs BJ, Paloyelis Y, Pantelis C, Parellada M, Pauli P, Picó-Pérez M, Picon FA, Piras F, Piras F, Plessen KJ, Pomarol-Clotet E, Preda A, Puig O, Quidé Y, Radua J, Ramos-Quiroga JA, Rasser PE, Rauer L, Reddy J, Redlich R, Reif A, Reneman L, Repple J, Retico A, Richarte V, Richter A, Rosa PGP, Rubia KK, Hashimoto R, Sacchet MD, Salvador R, Santonja J, Sarink K, Sarró S, Satterthwaite TD, Sawa A, Schall U, Schofield PR, Schrantee A, Seitz J, Serpa MH, Setién-Suero E, Shaw P, Shook D, Silk TJ, Sim K, Simon S, Simpson HB, Singh A, Skoch A, Skokauskas N, Soares JC, Soreni N, Soriano-Mas C, Spalletta G, Spaniel F, Lawrie SM, Stern ER, Stewart SE, Takayanagi Y, Temmingh HS, Tolin DF, Tomecek D, Tordesillas-Gutiérrez D, Tosetti M, Uhlmann A, van Amelsvoort T, van der Wee NJA, van der Werff SJA, van Haren NEM, van Wingen GA, Vance A, Vázquez-Bourgon J, Vecchio D, Venkatasubramanian G, Vieta E, Vilarroya O, Vives-Gilabert Y, Voineskos AN, Völzke H, von Polier GG, Walton E, Weickert TW, Weickert CS, Weideman AS, Wittfeld K, Wolf DH, Wu MJ, Yang TT, Yang K, Yoncheva Y, Yun JY, Cheng Y, Zanetti MV, Ziegler GC, Franke B, Hoogman M, et al. PMID: 32857118; PMCID: PMC7450410.
-
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project. Schizophr Res. 2021 04; 230:104-107. Berendsen S, Kapitein P, Schirmbeck F, van Tricht MJ, McGuire P, Morgan C, Gayer-Anderson C, Kempton MJ, Valmaggia L, Quattrone D, di Forti M, van der Gaag M, Kirkbride JB, Jongsma HE, Jones PB, Parellada M, Arango C, Arrojo M, Bernardo M, Sanjuán J, Santos JL, Szöke A, Tortelli A, Llorca PM, Tarricone I, Tripoli G, Ferraro L, La Cascia C, Lasalvia A, Tosato S, Menezes PR, Del-Ben CM, Nelson B, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BPF, van Os J, Velthorst E, de Haan L, EU-GEI High Risk Study. PMID: 33243716.
-
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. Nat Med. 2020 12; 26(12):1912-1918. Davies RW, Fiksinski AM, Breetvelt EJ, Williams NM, Hooper SR, Monfeuga T, Bassett AS, Owen MJ, Gur RE, Morrow BE, McDonald-McGinn DM, Swillen A, Chow EWC, van den Bree M, Emanuel BS, Vermeesch JR, van Amelsvoort T, Arango C, Armando M, Campbell LE, Cubells JF, Eliez S, Garcia-Minaur S, Gothelf D, Kates WR, Murphy KC, Murphy CM, Murphy DG, Philip N, Repetto GM, Shashi V, Simon TJ, Suñer DH, Vicari S, Scherer SW, International 22q11.2 Brain and Behavior Consortium, Bearden CE, Vorstman JAS. PMID: 33169016; PMCID: PMC7975627.
-
Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis. Eur Neuropsychopharmacol. 2020 12; 41:28-39. Salazar de Pablo G, De Micheli A, Nieman DH, Correll CU, Kessing LV, Pfennig A, Bechdolf A, Borgwardt S, Arango C, van Amelsvoort T, Vieta E, Solmi M, Oliver D, Catalan A, Verdino V, Di Maggio L, Bonoldi I, Vaquerizo-Serrano J, Baccaredda Boy O, Provenzani U, Ruzzi F, Calorio F, Nosari G, Di Marco B, Famularo I, Molteni S, Filosi E, Mensi M, Balottin U, Politi P, Shin JI, Fusar-Poli P. PMID: 33162291.
-
DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders. Front Psychiatry. 2020; 11:568982. Salazar de Pablo G, Guinart D, Cornblatt BA, Auther AM, Carrión RE, Carbon M, Jiménez-Fernández S, Vernal DL, Walitza S, Gerstenberg M, Saba R, Lo Cascio N, Brandizzi M, Arango C, Moreno C, Van Meter A, Fusar-Poli P, Correll CU. PMID: 33192693; PMCID: PMC7609900.
-
Intracranial and subcortical volumes in adolescents with early-onset psychosis: A multisite mega-analysis from the ENIGMA consortium. Hum Brain Mapp. 2022 01; 43(1):373-384. Gurholt TP, Lonning V, Nerland S, Jørgensen KN, Haukvik UK, Alloza C, Arango C, Barth C, Bearden CE, Berk M, Bohman H, Dandash O, Díaz-Caneja CM, Edbom CT, van Erp TGM, Fett AJ, Frangou S, Goldstein BI, Grigorian A, Jahanshad N, James AC, Janssen J, Johannessen C, Karlsgodt KH, Kempton MJ, Kochunov P, Krabbendam L, Kyriakopoulos M, Lundberg M, MacIntosh BJ, Rund BR, Smelror RE, Sultan A, Tamnes CK, Thomopoulos SI, Vajdi A, Wedervang-Resell K, Myhre AM, Andreassen OA, Thompson PM, Agartz I, ENIGMA-EOP Working Group. PMID: 33017498; PMCID: PMC8675418.
-
Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention. J Child Psychol Psychiatry. 2021 05; 62(5):657-673. Catalan A, Salazar de Pablo G, Vaquerizo Serrano J, Mosillo P, Baldwin H, Fernández-Rivas A, Moreno C, Arango C, Correll CU, Bonoldi I, Fusar-Poli P. PMID: 32924144.
-
Risk and protective factors for mental disorders with onset in childhood/adolescence: An umbrella review of published meta-analyses of observational longitudinal studies. Neurosci Biobehav Rev. 2021 01; 120:565-573. Solmi M, Dragioti E, Arango C, Radua J, Ostinelli E, Kilic O, Yilmaz UE, Yalcinay-Inan M, Soares FC, Mariano L, Mosillo P, Cortese S, Correll CU, Carvalho AF, Shin JI, Fusar-Poli P. PMID: 32931804.
-
How mental health care should change as a consequence of the COVID-19 pandemic. Lancet Psychiatry. 2020 09; 7(9):813-824. Moreno C, Wykes T, Galderisi S, Nordentoft M, Crossley N, Jones N, Cannon M, Correll CU, Byrne L, Carr S, Chen EYH, Gorwood P, Johnson S, Kärkkäinen H, Krystal JH, Lee J, Lieberman J, López-Jaramillo C, Männikkö M, Phillips MR, Uchida H, Vieta E, Vita A, Arango C. PMID: 32682460; PMCID: PMC7365642.
-
Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention. JAMA Psychiatry. 2020 07 01; 77(7):755-765. Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, Galderisi S, Bechdolf A, Pfennig A, Kessing LV, van Amelsvoort T, Nieman DH, Domschke K, Krebs MO, Koutsouleris N, McGuire P, Do KQ, Arango C. PMID: 32159746.
-
Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis. J Affect Disord. 2020 10 01; 275:48-57. Salazar de Pablo G, Vaquerizo-Serrano J, Catalan A, Arango C, Moreno C, Ferre F, Shin JI, Sullivan S, Brondino N, Solmi M, Fusar-Poli P. PMID: 32658823; PMCID: PMC7314697.
-
Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups. Am J Psychiatry. 2020 09 01; 177(9):834-843. Boedhoe PSW, van Rooij D, Hoogman M, Twisk JWR, Schmaal L, Abe Y, Alonso P, Ameis SH, Anikin A, Anticevic A, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Banaschewski T, Baranov A, Batistuzzo MC, Baumeister S, Baur-Streubel R, Behrmann M, Bellgrove MA, Benedetti F, Beucke JC, Biederman J, Bollettini I, Bose A, Bralten J, Bramati IE, Brandeis D, Brem S, Brennan BP, Busatto GF, Calderoni S, Calvo A, Calvo R, Castellanos FX, Cercignani M, Chaim-Avancini TM, Chantiluke KC, Cheng Y, Cho KIK, Christakou A, Coghill D, Conzelmann A, Cubillo AI, Dale AM, Dallaspezia S, Daly E, Denys D, Deruelle C, Di Martino A, Dinstein I, Doyle AE, Durston S, Earl EA, Ecker C, Ehrlich S, Ely BA, Epstein JN, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Fedor J, Feng X, Feusner JD, Fitzgerald J, Fitzgerald KD, Fouche JP, Freitag CM, Fridgeirsson EA, Frodl T, Gabel MC, Gallagher L, Gogberashvili T, Gori I, Gruner P, Gürsel DA, Haar S, Haavik J, Hall GB, Harrison NA, Hartman CA, Heslenfeld DJ, Hirano Y, Hoekstra PJ, Hoexter MQ, Hohmann S, Høvik MF, Hu H, Huyser C, Jahanshad N, Jalbrzikowski M, James A, Janssen J, Jaspers-Fayer F, Jernigan TL, Kapilushniy D, Kardatzki B, Karkashadze G, Kathmann N, Kaufmann C, Kelly C, Khadka S, King JA, Koch K, Kohls G, Konrad K, Kuno M, Kuntsi J, Kvale G, Kwon JS, Lázaro L, Lera-Miguel S, Lesch KP, Hoekstra L, Liu Y, Lochner C, Louza MR, Luna B, Lundervold AJ, Malpas CB, Marques P, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Mattos P, McCarthy H, McGrath J, Mehta MA, Menchón JM, Mennes M, Martinho MM, Moreira PS, Morer A, Morgado P, Muratori F, Murphy CM, Murphy DGM, Nakagawa A, Nakamae T, Nakao T, Namazova-Baranova L, Narayanaswamy JC, Nicolau R, Nigg JT, Novotny SE, Nurmi EL, Weiss EO, O'Gorman Tuura RL, O'Hearn K, O'Neill J, Oosterlaan J, Oranje B, Paloyelis Y, Parellada M, Pauli P, Perriello C, Piacentini J, Piras F, Piras F, Plessen KJ, Puig O, Ramos-Quiroga JA, Reddy YCJ, Reif A, Reneman L, Retico A, Rosa PGP, Rubia K, Rus OG, Sakai Y, Schrantee A, Schwarz L, Schweren LJS, Seitz J, Shaw P, Shook D, Silk TJ, Simpson HB, Skokauskas N, Soliva Vila JC, Solovieva A, Soreni N, Soriano-Mas C, Spalletta G, Stern ER, Stevens MC, Stewart SE, Sudre G, Szeszko PR, Tamm L, Taylor MJ, Tolin DF, Tosetti M, Tovar-Moll F, Tsuchiyagaito A, van Erp TGM, van Wingen GA, Vance A, Venkatasubramanian G, Vilarroya O, Vives-Gilabert Y, von Polier GG, Walitza S, Wallace GL, Wang Z, Wolfers T, Yoncheva YN, Yun JY, Zanetti MV, Zhou F, Ziegler GC, Zierhut KC, Zwiers MP, ENIGMA ADHD working group, ENIGMA ASD working group, ENIGMA OCD working group, Thompson PM, Stein DJ, Buitelaar J, Franke B, van den Heuvel OA. PMID: 32539527; PMCID: PMC8296070.
-
Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA. Neuroimage. 2020 09; 218:116956. Radua J, Vieta E, Shinohara R, Kochunov P, Quidé Y, Green MJ, Weickert CS, Weickert T, Bruggemann J, Kircher T, Nenadic I, Cairns MJ, Seal M, Schall U, Henskens F, Fullerton JM, Mowry B, Pantelis C, Lenroot R, Cropley V, Loughland C, Scott R, Wolf D, Satterthwaite TD, Tan Y, Sim K, Piras F, Spalletta G, Banaj N, Pomarol-Clotet E, Solanes A, Albajes-Eizagirre A, Canales-Rodríguez EJ, Sarro S, Di Giorgio A, Bertolino A, Stäblein M, Oertel V, Knöchel C, Borgwardt S, du Plessis S, Yun JY, Kwon JS, Dannlowski U, Hahn T, Grotegerd D, Alloza C, Arango C, Janssen J, Díaz-Caneja C, Jiang W, Calhoun V, Ehrlich S, Yang K, Cascella NG, Takayanagi Y, Sawa A, Tomyshev A, Lebedeva I, Kaleda V, Kirschner M, Hoschl C, Tomecek D, Skoch A, van Amelsvoort T, Bakker G, James A, Preda A, Weideman A, Stein DJ, Howells F, Uhlmann A, Temmingh H, López-Jaramillo C, Díaz-Zuluaga A, Fortea L, Martinez-Heras E, Solana E, Llufriu S, Jahanshad N, Thompson P, Turner J, van Erp T, ENIGMA Consortium collaborators. PMID: 32470572; PMCID: PMC7524039.
-
Psychiatry in the aftermath of COVID-19. Rev Psiquiatr Salud Ment (Engl Ed). 2020 Apr - Jun; 13(2):105-110. Vieta E, Pérez V, Arango C. PMID: 32376131; PMCID: PMC7833677.
-
Psychiatry in the aftermath of COVID-19. Rev Psiquiatr Salud Ment. 2020 Apr-Jun; 13(2):105-110. Vieta E, Pérez V, Arango C. PMID: 38620300; PMCID: PMC7177054.
-
Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial. Psychiatry Res. 2020 07; 289:112970. Baandrup L, Allerup P, Nielsen MØ, Bak N, Düring SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, Kahn RS, Glenthøj BY. PMID: 32438207.
-
The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA Consortium. Am J Psychiatry. 2020 06 01; 177(6):537-547. Holleran L, Kelly S, Alloza C, Agartz I, Andreassen OA, Arango C, Banaj N, Calhoun V, Cannon D, Carr V, Corvin A, Glahn DC, Gur R, Hong E, Hoschl C, Howells FM, James A, Janssen J, Kochunov P, Lawrie SM, Liu J, Martinez C, McDonald C, Morris D, Mothersill D, Pantelis C, Piras F, Potkin S, Rasser PE, Roalf D, Rowland L, Satterthwaite T, Schall U, Spalletta G, Spaniel F, Stein DJ, Uhlmann A, Voineskos A, Zalesky A, van Erp TGM, Turner JA, Deary IJ, Thompson PM, Jahanshad N, Donohoe G. PMID: 32212855; PMCID: PMC7938666.
-
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice. Schizophr Bull. 2020 02 26; 46(2):432-441. Tognin S, van Hell HH, Merritt K, Winter-van Rossum I, Bossong MG, Kempton MJ, Modinos G, Fusar-Poli P, Mechelli A, Dazzan P, Maat A, de Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Bressan R, Kwon JS, Weiser M, Mizrahi R, Sachs G, Maatz A, Kahn R, McGuire P, PSYSCAN Consortium. PMID: 31424555; PMCID: PMC7043057.
-
Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents. J Child Adolesc Psychopharmacol. 2020 05; 30(4):222-234. Salazar de Pablo G, Guinart D, Cornblatt BA, Auther AM, Carrión RE, Carbon M, Jiménez-Fernández S, Vernal DL, Walitza S, Gerstenberg M, Saba R, Lo Cascio N, Brandizzi M, Arango C, Moreno C, Van Meter A, Correll CU. PMID: 32083495; PMCID: PMC7232658.
-
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Mol Psychiatry. 2021 08; 26(8):4496-4510. Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, Emanuel BS, Vermeesch JR, Warren ST, Owen MJ, Chopra P, Cutler DJ, Duncan R, Kotlar AV, Mulle JG, Voss AJ, Zwick ME, Diacou A, Golden A, Guo T, Lin JR, Wang T, Zhang Z, Zhao Y, Marshall C, Merico D, Jin A, Lilley B, Salmons HI, Tran O, Holmans P, Pardinas A, Walters JTR, Demaerel W, Boot E, Butcher NJ, Costain GA, Lowther C, Evers R, van Amelsvoort TAMJ, van Duin E, Vingerhoets C, Breckpot J, Devriendt K, Vergaelen E, Vogels A, Crowley TB, McGinn DE, Moss EM, Sharkus RJ, Unolt M, Zackai EH, Calkins ME, Gallagher RS, Gur RC, Tang SX, Fritsch R, Ornstein C, Repetto GM, Breetvelt E, Duijff SN, Fiksinski A, Moss H, Niarchou M, Murphy KC, Prasad SE, Daly EM, Gudbrandsen M, Murphy CM, Murphy DG, Buzzanca A, Fabio FD, Digilio MC, Pontillo M, Marino B, Vicari S, Coleman K, Cubells JF, Ousley OY, Carmel M, Gothelf D, Mekori-Domachevsky E, Michaelovsky E, Weinberger R, Weizman A, Kushan L, Jalbrzikowski M, Armando M, Eliez S, Sandini C, Schneider M, Béna FS, Antshel KM, Fremont W, Kates WR, Belzeaux R, Busa T, Philip N, Campbell LE, McCabe KL, Hooper SR, Schoch K, Shashi V, Simon TJ, Tassone F, Arango C, Fraguas D, García-Miñaúr S, Morey-Canyelles J, Rosell J, Suñer DH, Raventos-Simic J, International 22q11.2DS Brain and Behavior Consortium, Epstein MP, Williams NM, Bassett AS. PMID: 32015465; PMCID: PMC7396297.
-
Needs of people with psychosis and their caregivers: «In their own voice». Rev Psiquiatr Salud Ment (Engl Ed). 2020 Apr - Jun; 13(2):80-89. Lahera G, Cid J, Gonzalez-Pinto A, Cabrera A, Mariner C, Vieta E, Arango C, Crespo-Facorro B. PMID: 31937434.
-
What is good mental health? A scoping review. Eur Neuropsychopharmacol. 2020 02; 31:33-46. Fusar-Poli P, Salazar de Pablo G, De Micheli A, Nieman DH, Correll CU, Kessing LV, Pfennig A, Bechdolf A, Borgwardt S, Arango C, van Amelsvoort T. PMID: 31901337.
-
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP). Eur Neuropsychopharmacol. 2019 12; 29(12):1301-1311. Fusar-Poli P, Bauer M, Borgwardt S, Bechdolf A, Correll CU, Do KQ, Domschke K, Galderisi S, Kessing LV, Koutsouleris N, Krebs MO, Lennox B, McGuire P, Meyer-Lindenberg A, Millan MJ, Nieman D, Pfennig A, Sand M, Whenert A, van Amelsvoort T, Arango C. PMID: 31606303.
-
Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study. Mol Psychiatry. 2020 11; 25(11):2818-2831. Villalón-Reina JE, Martínez K, Qu X, Ching CRK, Nir TM, Kothapalli D, Corbin C, Sun D, Lin A, Forsyth JK, Kushan L, Vajdi A, Jalbrzikowski M, Hansen L, Jonas RK, van Amelsvoort T, Bakker G, Kates WR, Antshel KM, Fremont W, Campbell LE, McCabe KL, Daly E, Gudbrandsen M, Murphy CM, Murphy D, Craig M, Emanuel B, McDonald-McGinn DM, Vorstman JAS, Fiksinski AM, Koops S, Ruparel K, Roalf D, Gur RE, Eric Schmitt J, Simon TJ, Goodrich-Hunsaker NJ, Durdle CA, Doherty JL, Cunningham AC, van den Bree M, Linden DEJ, Owen M, Moss H, Kelly S, Donohoe G, Murphy KC, Arango C, Jahanshad N, Thompson PM, Bearden CE. PMID: 31358905; PMCID: PMC6986984.
-
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study. Transl Psychiatry. 2019 Jun 21; 9(1):171. Martinuzzi E, Barbosa S, Daoudlarian D, Ali WBH, Gilet C, Fillatre L, Khalfallah O, Troudet R, Jamain S, Fond G, Sommer I, Leucht S, Dazzan P, McGuire P, Arango C, Diaz-Caneja CM, Fleischhacker W, Rujescu D, Glenthøj B, Winter I, Kahn RS, Yolken R, Lewis S, Drake R, Davidovic L, Leboyer M, Glaichenhaus N, OPTiMiSE Study Group. PMID: 31227688; PMCID: PMC6588557.
-
10Kin1day: A Bottom-Up Neuroimaging Initiative. Front Neurol. 2019; 10:425. van den Heuvel MP, Scholtens LH, van der Burgh HK, Agosta F, Alloza C, Arango C, Auyeung B, Baron-Cohen S, Basaia S, Benders MJNL, Beyer F, Booij L, Braun KPJ, Filho GB, Cahn W, Cannon DM, Chaim-Avancini TM, Chan SSM, Chen EYH, Crespo-Facorro B, Crone EA, Dannlowski U, de Zwarte SMC, Dietsche B, Donohoe G, Plessis SD, Durston S, Díaz-Caneja CM, Díaz-Zuluaga AM, Emsley R, Filippi M, Frodl T, Gorges M, Graff B, Grotegerd D, Gasecki D, Hall JM, Holleran L, Holt R, Hopman HJ, Jansen A, Janssen J, Jodzio K, Jäncke L, Kaleda VG, Kassubek J, Masouleh SK, Kircher T, Koevoets MGJC, Kostic VS, Krug A, Lawrie SM, Lebedeva IS, Lee EHM, Lett TA, Lewis SJG, Liem F, Lombardo MV, Lopez-Jaramillo C, Margulies DS, Markett S, Marques P, Martínez-Zalacaín I, McDonald C, McIntosh AM, McPhilemy G, Meinert SL, Menchón JM, Montag C, Moreira PS, Morgado P, Mothersill DO, Mérillat S, Müller HP, Nabulsi L, Najt P, Narkiewicz K, Naumczyk P, Oranje B, Ortiz-Garcia de la Foz V, Peper JS, Pineda JA, Rasser PE, Redlich R, Repple J, Reuter M, Rosa PGP, Ruigrok ANV, Sabisz A, Schall U, Seedat S, Serpa MH, Skouras S, Soriano-Mas C, Sousa N, Szurowska E, Tomyshev AS, Tordesillas-Gutierrez D, Valk SL, van den Berg LH, van Erp TGM, van Haren NEM, van Leeuwen JMC, Villringer A, Vinkers CH, Vollmar C, Waller L, Walter H, Whalley HC, Witkowska M, Witte AV, Zanetti MV, Zhang R, de Lange SC. PMID: 31133958; PMCID: PMC6524614.
-
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study. Transl Psychiatry. 2019 01 17; 9(1):20. Martinuzzi E, Barbosa S, Daoudlarian D, Bel Haj Ali W, Gilet C, Fillatre L, Khalfallah O, Troudet R, Jamain S, Fond G, Sommer I, Leucht S, Dazzan P, McGuire P, Arango C, Diaz-Caneja CM, Fleischhacker W, Rujescu D, Glenthøj B, Winter I, Kahn RS, Yolken R, Lewis S, Drake R, Davidovic L, Leboyer M, Glaichenhaus N, OPTiMiSE Study Group. PMID: 30655509; PMCID: PMC6336802.
-
Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure. Schizophr Bull. 2019 01 01; 45(1):69-79. Downs J, Dean H, Lechler S, Sears N, Patel R, Shetty H, Hotopf M, Ford T, Kyriakopoulos M, Diaz-Caneja CM, Arango C, MacCabe JH, Hayes RD, Pina-Camacho L. PMID: 29370404; PMCID: PMC6293208.
-
Preventive strategies for mental health. Lancet Psychiatry. 2018 07; 5(7):591-604. Arango C, Díaz-Caneja CM, McGorry PD, Rapoport J, Sommer IE, Vorstman JA, McDaid D, Marín O, Serrano-Drozdowskyj E, Freedman R, Carpenter W. PMID: 29773478.
-
Early intervention in psychosis: From clinical intervention to health system implementation. Early Interv Psychiatry. 2018 08; 12(4):757-764. Csillag C, Nordentoft M, Mizuno M, McDaid D, Arango C, Smith J, Lora A, Verma S, Di Fiandra T, Jones PB. PMID: 29143456.
-
The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1233-e1241. Downs JM, Lechler S, Dean H, Sears N, Patel R, Shetty H, Simonoff E, Hotopf M, Ford TJ, Diaz-Caneja CM, Arango C, MacCabe JH, Hayes RD, Pina-Camacho L. PMID: 29125721; PMCID: PMC6037287.
-
Developmental Differences Between Schizophrenia and Bipolar Disorder. Schizophr Bull. 2017 10 21; 43(6):1176-1189. Parellada M, Gomez-Vallejo S, Burdeus M, Arango C. PMID: 29045744; PMCID: PMC5737496.
-
Moving interventions from after to before diagnosis. World Psychiatry. 2017 Oct; 16(3):275-276. Sommer IE, Arango C. PMID: 28941115; PMCID: PMC5608816.
-
Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis. Int J Neuropsychopharmacol. 2017 06 01; 20(6):435-444. Fraguas D, Díaz-Caneja CM, Rodríguez-Quiroga A, Arango C. PMID: 28575316; PMCID: PMC5452799.
-
Early interventions in risk groups for schizophrenia: what are we waiting for? NPJ Schizophr. 2016; 2:16003. Sommer IE, Bearden CE, van Dellen E, Breetvelt EJ, Duijff SN, Maijer K, van Amelsvoort T, de Haan L, Gur RE, Arango C, Díaz-Caneja CM, Vinkers CH, Vorstman JA. PMID: 27336054; PMCID: PMC4849435.
-
Predictors of functional and clinical outcome in early-onset first-episode psychosis: the child and adolescent first episode of psychosis (CAFEPS) study. J Clin Psychiatry. 2015 Nov; 76(11):e1441-8. Parellada M, Castro-Fornieles J, Gonzalez-Pinto A, Pina-Camacho L, Moreno D, Rapado-Castro M, Otero S, de la Serna E, Moreno C, Baeza I, Graell M, Arango C. PMID: 26580481.
-
First-Episode Psychosis Research: Time to Move Forward (by Looking Backwards). Schizophr Bull. 2015 Nov; 41(6):1205-6. Arango C. PMID: 26392627; PMCID: PMC4601723.
-
A integral treatment for attention deficit hyperactivity disorder in Europe. Rev Psiquiatr Salud Ment. 2015 Oct-Dec; 8(4):197-8. Arango C. PMID: 26059836.
-
Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophr Bull. 2015 May; 41(3):574-83. Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, Meyer-Lindenberg A, Kahn R, Rujescu D, Sommer I, Winter I, McGuire P. PMID: 25800248; PMCID: PMC4393706.
-
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention. Schizophr Bull. 2015 May; 41(3):584-96. Drake RJ, Nordentoft M, Haddock G, Arango C, Fleischhacker WW, Glenthøj B, Leboyer M, Leucht S, Leweke M, McGuire P, Meyer-Lindenberg A, Rujescu D, Sommer IE, Kahn RS, Lewis SW. PMID: 25750247; PMCID: PMC4393703.
-
Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model. Eur Child Adolesc Psychiatry. 2015 Apr; 24(4):427-40. Pina-Camacho L, Garcia-Prieto J, Parellada M, Castro-Fornieles J, Gonzalez-Pinto AM, Bombin I, Graell M, Paya B, Rapado-Castro M, Janssen J, Baeza I, Del Pozo F, Desco M, Arango C. PMID: 25109600.
-
Practitioner review: Long-term pharmacological treatment of pediatric bipolar disorder. J Child Psychol Psychiatry. 2014 Sep; 55(9):959-80. Díaz-Caneja CM, Moreno C, Llorente C, Espliego A, Arango C, Moreno D. PMID: 24905547.
-
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull. 2014 Jul; 40(4):729-36. European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GE, van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, van Zelst C, Bruggeman R, Reininghaus U, Morgan C, Murray RM, Di Forti M, McGuire P, Valmaggia LR, Kempton MJ, Gayer-Anderson C, Hubbard K, Beards S, Stilo SA, Onyejiaka A, Bourque F, Modinos G, Tognin S, Calem M, O'Donovan MC, Owen MJ, Holmans P, Williams N, Craddock N, Richards A, Humphreys I, Meyer-Lindenberg A, Leweke FM, Tost H, Akdeniz C, Rohleder C, Bumb JM, Schwarz E, Alptekin K, Üçok A, Saka MC, Atbasoglu EC, Gülöksüz S, Gumus-Akay G, Cihan B, Karadag H, Soygür H, Cankurtaran ES, Ulusoy S, Akdede B, Binbay T, Ayer A, Noyan H, Karadayi G, Akturan E, Ulas H, Arango C, Parellada M, Bernardo M, Sanjuán J, Bobes J, Arrojo M, Santos JL, Cuadrado P, Rodríguez Solano JJ, Carracedo A, García Bernardo E, Roldán L, López G, Cabrera B, Cruz S, Díaz Mesa EM, Pouso M, Jiménez E, Sánchez T, Rapado M, González E, Martínez C, Sánchez E, Olmeda MS, de Haan L, Velthorst E, van der Gaag M, Selten JP, van Dam D, van der Ven E, van der Meer F, Messchaert E, Kraan T, Burger N, Leboyer M, Szoke A, Schürhoff F, Llorca PM, Jamain S, Tortelli A, Frijda F, Vilain J, Galliot AM, Baudin G, Ferchiou A, Richard JR, Bulzacka E, Charpeaud T, Tronche AM, De Hert M, van Winkel R, Decoster J, Derom C, Thiery E, Stefanis NC, Sachs G, Aschauer H, Lasser I, Winklbaur B, Schlögelhofer M, Riecher-Rössler A, Borgwardt S, Walter A, Harrisberger F, Smieskova R, Rapp C, Ittig S, Soguel-dit-Piquard F, Studerus E, Klosterkötter J, Ruhrmann S, Paruch J, Julkowski D, Hilboll D, Sham PC, Cherny SS, Chen EY, Campbell DD, Li M, Romeo-Casabona CM, Emaldi Cirión A, Urruela Mora A, Jones P, Kirkbride J, Cannon M, Rujescu D, Tarricone I, Berardi D, Bonora E, Seri M, Marcacci T, Chiri L, Chierzi F, Storbini V, Braca M, Minenna MG, Donegani I, Fioritti A, La Barbera D, La Cascia CE, Mulè A, Sideli L, Sartorio R, Ferraro L, Tripoli G, Seminerio F, Marinaro AM, McGorry P, Nelson B, Amminger GP, Pantelis C, Menezes PR, Del-Ben CM, Gallo Tenan SH, Shuhama R, Ruggeri M, Tosato S, Lasalvia A, Bonetto C, Ira E, Nordentoft M, Krebs MO, Barrantes-Vidal N, Cristóbal P, Kwapil TR, Brietzke E, Bressan RA, Gadelha A, Maric NP, Andric S, Mihaljevic M, Mirjanic T. PMID: 24860087; PMCID: PMC4059449.
-
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res. 2014 Jan; 23 Suppl 1:1-14. Haro JM, Ayuso-Mateos JL, Bitter I, Demotes-Mainard J, Leboyer M, Lewis SW, Linszen D, Maj M, McDaid D, Meyer-Lindenberg A, Robbins TW, Schumann G, Thornicroft G, Van Der Feltz-Cornelis C, Van Os J, Wahlbeck K, Wittchen HU, Wykes T, Arango C, Bickenbach J, Brunn M, Cammarata P, Chevreul K, Evans-Lacko S, Finocchiaro C, Fiorillo A, Forsman AK, Hazo JB, Knappe S, Kuepper R, Luciano M, Miret M, Obradors-Tarragó C, Pagano G, Papp S, Walker-Tilley T. PMID: 24375532; PMCID: PMC6878332.
-
Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders. Schizophr Bull. 2014 Mar; 40 Suppl 2:S138-46. Arango C, Fraguas D, Parellada M. PMID: 24371326; PMCID: PMC3934406.
-
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. Eur Child Adolesc Psychiatry. 2014 Dec; 23(12):1149-60. Glennon J, Purper-Ouakil D, Bakker M, Zuddas A, Hoekstra P, Schulze U, Castro-Fornieles J, Santosh PJ, Arango C, Kölch M, Coghill D, Flamarique I, Penzol MJ, Wan M, Murray M, Wong IC, Danckaerts M, Bonnot O, Falissard B, Masi G, Fegert JM, Vicari S, Carucci S, Dittmann RW, Buitelaar JK, PERS Consortium. PMID: 24337449; PMCID: PMC4246122.
-
Psychopathology in children and adolescents with ASD without mental retardation. J Autism Dev Disord. 2013 Oct; 43(10):2442-9. Caamaño M, Boada L, Merchán-Naranjo J, Moreno C, Llorente C, Moreno D, Arango C, Parellada M. PMID: 23468070.
-
Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey. World Psychiatry. 2013 Oct; 12(3):251-7. Moreno C, Nuevo R, Chatterji S, Verdes E, Arango C, Ayuso-Mateos JL. PMID: 24096791; PMCID: PMC3799256.
-
Validation of a European Spanish-version of the University of California performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorder. Schizophr Res. 2013 Nov; 150(2-3):421-6. Garcia-Portilla MP, Gomar JJ, Bobes-Bascaran MT, Menendez-Miranda I, Saiz PA, Muñiz J, Arango C, Patterson TL, Harvey PD, Bobes J, Goldberg TE. PMID: 24055246.
-
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophr Res. 2013 Nov; 150(2-3):328-33. Marder SR, Alphs L, Anghelescu IG, Arango C, Barnes TR, Caers I, Daniel DG, Dunayevich E, Fleischhacker WW, Garibaldi G, Green MF, Harvey PD, Kahn RS, Kane JM, Keefe RS, Kinon B, Leucht S, Lindenmayer JP, Malhotra AK, Stauffer V, Umbricht D, Wesnes K, Kapur S, Rabinowitz J. PMID: 24028744.
-
White matter microstructure correlates of mathematical giftedness and intelligence quotient. Hum Brain Mapp. 2014 Jun; 35(6):2619-31. Navas-Sánchez FJ, Alemán-Gómez Y, Sánchez-Gonzalez J, Guzmán-De-Villoria JA, Franco C, Robles O, Arango C, Desco M. PMID: 24038774; PMCID: PMC6868969.
-
Prevalence of premorbid personality disorder and its clinical correlates in patients with delusional disorder. Psychiatry Res. 2013 Dec 30; 210(3):986-93. de Portugal E, Díaz-Caneja CM, González-Molinier M, de Castro MJ, del Amo V, Arango C, Cervilla JA. PMID: 23993136.
-
Pharmacological approaches to treating negative symptoms: a review of clinical trials. Schizophr Res. 2013 Nov; 150(2-3):346-52. Arango C, Garibaldi G, Marder SR. PMID: 23938176.
-
Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability. J Clin Psychopharmacol. 2013 Aug; 33(4):463-71. Noguera A, Ballesta P, Baeza I, Arango C, de la Serna E, González-Pinto A, Parellada M, Graell M, Moreno C, Otero S, Castro-Fornieles J. PMID: 23771198.
-
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013 Aug; 170(8):852-9. Torrent C, Bonnin Cdel M, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, Crespo JM, Ibáñez Á, Garcia-Portilla MP, Tabarés-Seisdedos R, Arango C, Colom F, Solé B, Pacchiarotti I, Rosa AR, Ayuso-Mateos JL, Anaya C, Fernández P, Landín-Romero R, Alonso-Lana S, Ortiz-Gil J, Segura B, Barbeito S, Vega P, Fernández M, Ugarte A, Subirà M, Cerrillo E, Custal N, Menchón JM, Saiz-Ruiz J, Rodao JM, Isella S, Alegría A, Al-Halabi S, Bobes J, Galván G, Saiz PA, Balanzá-Martínez V, Selva G, Fuentes-Durá I, Correa P, Mayoral M, Chiclana G, Merchan-Naranjo J, Rapado-Castro M, Salamero M, Vieta E. PMID: 23511717.
-
Child neuropsychopharmacology: good news… the glass is half full. World Psychiatry. 2013 Jun; 12(2):128-9. Arango C. PMID: 23737417; PMCID: PMC3683260.
-
Premorbid impairments in early-onset psychosis: differences between patients with schizophrenia and bipolar disorder. Schizophr Res. 2013 May; 146(1-3):103-10. Payá B, Rodríguez-Sánchez JM, Otero S, Muñoz P, Castro-Fornieles J, Parellada M, Gonzalez-Pinto A, Soutullo C, Baeza I, Rapado-Castro M, Sáenz-Herrero M, Moreno D, Arango C. PMID: 23465966.
-
Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Rev Psiquiatr Salud Ment. 2013 Jan-Mar; 6(1):4-16. Bernardo M, Bioque M, Parellada M, Saiz Ruiz J, Cuesta MJ, Llerena A, Sanjuán J, Castro-Fornieles J, Arango C, Cabrera B, PEPs Group. PMID: 23206389.
-
Polypharmacy with antidepressants in children and adolescents. Int J Neuropsychopharmacol. 2014 Jul; 17(7):1063-82. Díaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C. PMID: 23190624.
-
Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia. Schizophr Res. 2013 Jan; 143(1):125-31. de la Serna E, Andrés-Perpiñá S, Puig O, Baeza I, Bombin I, Bartrés-Faz D, Arango C, Gonzalez-Pinto A, Parellada M, Mayoral M, Graell M, Otero S, Guardia J, Castro-Fornieles J. PMID: 23182439.
-
Antioxidant defense system and family environment in adolescents with family history of psychosis. BMC Psychiatry. 2012 Nov 16; 12:200. Gonzalez-Pinto A, Martinez-Cengotitabengoa M, Arango C, Baeza I, Otero-Cuesta S, Graell-Berna M, Soutullo C, Leza JC, Micó JA. PMID: 23158023; PMCID: PMC3539933.
-
Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. J Clin Psychiatry. 2013 Jan; 74(1):59-66. Sanchez-Gistau V, Baeza I, Arango C, González-Pinto A, de la Serna E, Parellada M, Graell M, Paya B, Llorente C, Castro-Fornieles J. PMID: 23217983.
-
Autism spectrum disorder: does neuroimaging support the DSM-5 proposal for a symptom dyad? A systematic review of functional magnetic resonance imaging and diffusion tensor imaging studies. J Autism Dev Disord. 2012 Jul; 42(7):1326-41. Pina-Camacho L, Villero S, Fraguas D, Boada L, Janssen J, Navas-Sánchez FJ, Mayoral M, Llorente C, Arango C, Parellada M. PMID: 21932156.
-
Secondary effects of antipsychotic treatment in naive or quasi-naive children and adolescents: design of a follow-up protocol and baseline results. Rev Psiquiatr Salud Ment. 2012 Oct-Dec; 5(4):217-28. Merchán-Naranjo J, Tapia C, Bailón C, Moreno C, Baeza I, Calvo-Escalona R, Morer A, Martínez-Cantarero C, Nestares PA, Alda JÁ, Muñoz D, Arango C. PMID: 23021294.
-
Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord. 2012 May; 14(3):271-82. Moreno C, Hasin DS, Arango C, Oquendo MA, Vieta E, Liu S, Grant BF, Blanco C. PMID: 22548900; PMCID: PMC3349442.
-
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study. Schizophr Res. 2012 May; 137(1-3):58-65. Fraguas D, Gonzalez-Pinto A, Micó JA, Reig S, Parellada M, Martínez-Cengotitabengoa M, Castro-Fornieles J, Rapado-Castro M, Baeza I, Janssen J, Desco M, Leza JC, Arango C. PMID: 22365149.
-
Cortical structural abnormalities in deficit versus nondeficit schizophrenia. Schizophr Res. 2012 Apr; 136(1-3):51-4. Fischer BA, Keller WR, Arango C, Pearlson GD, McMahon RP, Meyer WA, Francis A, Kirkpatrick B, Carpenter WT, Buchanan RW. PMID: 22336954; PMCID: PMC3298625.
-
Plasma antioxidant capacity is reduced in Asperger syndrome. J Psychiatr Res. 2012 Mar; 46(3):394-401. Parellada M, Moreno C, Mac-Dowell K, Leza JC, Giraldez M, Bailón C, Castro C, Miranda-Azpiazu P, Fraguas D, Arango C. PMID: 22225920.
-
Estimation of the intelligence quotient using Wechsler Intelligence Scales in children and adolescents with Asperger syndrome. J Autism Dev Disord. 2012 Jan; 42(1):116-22. Merchán-Naranjo J, Mayoral M, Rapado-Castro M, Llorente C, Boada L, Arango C, Parellada M. PMID: 21455795.
-
Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry. 2012 Jan; 69(1):16-26. Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, González-Pinto A, Otero S, Baeza I, Moreno C, Graell M, Janssen J, Parellada M, Moreno D, Bargalló N, Desco M. PMID: 22213785.
-
Increased risk of diabetes mellitus among persons with psychotic symptoms: results from the WHO World Health Survey. J Clin Psychiatry. 2011 Dec; 72(12):1592-9. Nuevo R, Chatterji S, Fraguas D, Verdes E, Naidoo N, Arango C, Ayuso-Mateos JL. PMID: 22244021.
-
Regional specificity of thalamic volume deficits in male adolescents with early-onset psychosis. Br J Psychiatry. 2012 Jan; 200(1):30-6. Janssen J, Alemán-Gómez Y, Reig S, Schnack HG, Parellada M, Graell M, Moreno C, Moreno D, Mateos-Pérez JM, Udias JM, Arango C, Desco M. PMID: 22116979.
-
Placebo effect in child and adolescent psychiatric trials. Eur Neuropsychopharmacol. 2012 Nov; 22(11):787-99. Parellada M, Moreno C, Moreno M, Espliego A, de Portugal E, Arango C. PMID: 22030230.
-
Review: depot antipsychotics may reduce risk of relapse compared with oral antipsychotics in people with schizophrenia. Evid Based Ment Health. 2011 Nov; 14(4):112. Arango C. PMID: 21954154.
-
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet. 2011 Oct 15; 20(20):4076-81. Steinberg S, de Jong S, Irish Schizophrenia Genomics Consortium, Andreassen OA, Werge T, Børglum AD, Mors O, Mortensen PB, Gustafsson O, Costas J, Pietiläinen OP, Demontis D, Papiol S, Huttenlocher J, Mattheisen M, Breuer R, Vassos E, Giegling I, Fraser G, Walker N, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J, Paunio T, Agartz I, Melle I, Djurovic S, Strengman E, GROUP, Jürgens G, Glenthøj B, Terenius L, Hougaard DM, Ørntoft T, Wiuf C, Didriksen M, Hollegaard MV, Nordentoft M, van Winkel R, Kenis G, Abramova L, Kaleda V, Arrojo M, Sanjuán J, Arango C, Sperling S, Rossner M, Ribolsi M, Magni V, Siracusano A, Christiansen C, Kiemeney LA, Veldink J, van den Berg L, Ingason A, Muglia P, Murray R, Nöthen MM, Sigurdsson E, Petursson H, Thorsteinsdottir U, Kong A, Rubino IA, De Hert M, Réthelyi JM, Bitter I, Jönsson EG, Golimbet V, Carracedo A, Ehrenreich H, Craddock N, Owen MJ, O'Donovan MC, Wellcome Trust Case Control Consortium 2, Ruggeri M, Tosato S, Peltonen L, Ophoff RA, Collier DA, St Clair D, Rietschel M, Cichon S, Stefansson H, Rujescu D, Stefansson K. PMID: 21791550; PMCID: PMC3298077.
-
Two-year diagnostic stability in early-onset first-episode psychosis. J Child Psychol Psychiatry. 2011 Oct; 52(10):1089-98. Castro-Fornieles J, Baeza I, de la Serna E, Gonzalez-Pinto A, Parellada M, Graell M, Moreno D, Otero S, Arango C. PMID: 21770939.
-
Role of serotonergic-related systems in suicidal behavior: Data from a case-control association study. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 01; 35(6):1518-24. Saiz PA, García-Portilla P, Paredes B, Corcoran P, Arango C, Morales B, Sotomayor E, Alvarez V, Coto E, Flórez G, Bascaran MT, Bousoño M, Bobes J. PMID: 21575667.
-
Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics. Clin Nutr. 2011 Oct; 30(5):616-23. Cuerda C, Merchan-Naranjo J, Velasco C, Gutierrez A, Leiva M, de Castro MJ, Parellada M, Giráldez M, Bretón I, Camblor M, García-Peris P, Dulín E, Sanz I, Desco M, Arango C. PMID: 21492975.
-
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study. Eur Neuropsychopharmacol. 2011 Dec; 21(12):867-75. Arango C, Bobes J, Kirkpatrick B, Garcia-Garcia M, Rejas J. PMID: 21477998.
-
Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry. 2011 Feb 14; 11:26. Micó JA, Rojas-Corrales MO, Gibert-Rahola J, Parellada M, Moreno D, Fraguas D, Graell M, Gil J, Irazusta J, Castro-Fornieles J, Soutullo C, Arango C, Otero S, Navarro A, Baeza I, Martínez-Cengotitabengoa M, González-Pinto A. PMID: 21320302; PMCID: PMC3045298.
-
[Differential characteristics of the efficacy and tolerability of second-generation antipsychotics in the treatment of psychotic disorders in children and adolescents]. Rev Psiquiatr Salud Ment. 2010 Oct; 3(4):152-67. Fraguas D, Merchán-Naranjo J, Arango C. PMID: 23446038.
-
Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 2011 Feb; 20(2):67-70. Arango C. PMID: 21057834.
-
Neurological soft signs in juvenile patients with Asperger syndrome, early-onset psychosis, and healthy controls. Early Interv Psychiatry. 2010 Nov; 4(4):283-90. Mayoral M, Merchán-Naranjo J, Rapado M, Leiva M, Moreno C, Giráldez M, Arango C, Parellada M. PMID: 20977684.
-
Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. Schizophr Bull. 2011 Jan; 37(1):38-51. Parellada M, Boada L, Fraguas D, Reig S, Castro-Fornieles J, Moreno D, Gonzalez-Pinto A, Otero S, Rapado-Castro M, Graell M, Baeza I, Arango C. PMID: 20884756; PMCID: PMC3004178.
-
The continuum of psychotic symptoms in the general population: a cross-national study. Schizophr Bull. 2012 May; 38(3):475-85. Nuevo R, Chatterji S, Verdes E, Naidoo N, Arango C, Ayuso-Mateos JL. PMID: 20841326; PMCID: PMC3329982.
-
Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol. 2011 Aug; 21(8):621-45. Fraguas D, Correll CU, Merchán-Naranjo J, Rapado-Castro M, Parellada M, Moreno C, Arango C. PMID: 20702068.
-
[Quetiapine treatment in adolescents: A 6-month naturalistic study]. Rev Psiquiatr Salud Ment. 2010 Jul; 3(3):106-10. Fraguas D, Parellada M, Moreno D, Arango C. PMID: 23445997.
-
Interactions between functional serotonergic polymorphisms and demographic factors influence personality traits in healthy Spanish Caucasians. Psychiatr Genet. 2010 Aug; 20(4):171-8. Saiz PA, Garcia-Portilla MP, Herrero R, Arango C, Corcoran P, Morales B, Bascarán MT, Alvarez V, Coto E, Paredes B, Fernández JM, Bobes J. PMID: 20421848.
-
Can positive family factors be protective against the development of psychosis? Psychiatry Res. 2011 Mar 30; 186(1):28-33. González-Pinto A, Ruiz de Azúa S, Ibáñez B, Otero-Cuesta S, Castro-Fornieles J, Graell-Berna M, Ugarte A, Parellada M, Moreno D, Soutullo C, Baeza I, Arango C. PMID: 20627207.
-
Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis. Schizophr Bull. 2011 Nov; 37(6):1270-80. Reig S, Parellada M, Castro-Fornieles J, Janssen J, Moreno D, Baeza I, Bargalló N, González-Pinto A, Graell M, Ortuño F, Otero S, Arango C, Desco M. PMID: 20478821; PMCID: PMC3196940.
-
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res. 2010 Jun; 119(1-3):101-9. Bobes J, Arango C, Garcia-Garcia M, Rejas J. PMID: 20219322.
-
Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses. Bipolar Disord. 2010 Mar; 12(2):172-84. Moreno C, Merchán-Naranjo J, Alvarez M, Baeza I, Alda JA, Martínez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M, Arango C. PMID: 20402710.
-
Predominance of symptoms over time in early-onset psychosis: a principal component factor analysis of the Positive and Negative Syndrome Scale. J Clin Psychiatry. 2010 Mar; 71(3):327-37. Rapado-Castro M, Soutullo C, Fraguas D, Arango C, Payá B, Castro-Fornieles J, González-Pinto A, Parellada M, Graell M, Baeza I, Bombin I. PMID: 20331934.
-
Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers. J Nerv Ment Dis. 2010 Feb; 198(2):159-62. de la Serna E, Mayoral M, Baeza I, Arango C, Andrés P, Bombin I, González C, Rapado M, Robles O, Rodríguez-Sánchez JM, Zabala A, Castro-Fornieles J. PMID: 20145493.
-
Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull. 2011 May; 37(3):631-9. González-Pinto A, Alberich S, Barbeito S, Gutierrez M, Vega P, Ibáñez B, Haidar MK, Vieta E, Arango C. PMID: 19915168; PMCID: PMC3080669.
-
Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups. Eur Arch Psychiatry Clin Neurosci. 2010 Apr; 260(3):225-33. Zabala A, Rapado M, Arango C, Robles O, de la Serna E, González C, Rodríguez-Sánchez JM, Andrés P, Mayoral M, Bombín I. PMID: 19768481.
-
Polymorphisms of the IL-1 gene complex are associated with alcohol dependence in Spanish Caucasians: data from an association study. Alcohol Clin Exp Res. 2009 Dec; 33(12):2147-53. Saiz PA, Garcia-Portilla MP, Florez G, Corcoran P, Arango C, Morales B, Leza JC, Alvarez S, Díaz EM, Alvarez V, Coto E, Nogueiras L, Bobes J. PMID: 19764937.
-
Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 01; 34(1):26-31. Sáiz PA, García-Portilla MP, Arango C, Morales B, Arias B, Corcoran P, Fernández JM, Alvarez V, Coto E, Bascarán MT, Bousoño M, Fañanas L, Bobes J. PMID: 19766158.
-
Brain morphology and neurological soft signs in adolescents with first-episode psychosis. Br J Psychiatry. 2009 Sep; 195(3):227-33. Janssen J, Diaz-Caneja A, Reig S, Bombín I, Mayoral M, Parellada M, Graell M, Moreno D, Zabala A, Vazquez VG, Desco M, Arango C. PMID: 19721112.
-
Gyral and sulcal cortical thinning in adolescents with first episode early-onset psychosis. Biol Psychiatry. 2009 Dec 01; 66(11):1047-54. Janssen J, Reig S, Alemán Y, Schnack H, Udias JM, Parellada M, Graell M, Moreno D, Zabala A, Balaban E, Desco M, Arango C. PMID: 19717139.
-
Cognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosis. Schizophr Bull. 2011 Mar; 37(2):405-15. Robles O, Zabala A, Bombín I, Parellada M, Moreno D, Ruiz-Sancho A, Arango C. PMID: 19706697; PMCID: PMC3044627.
-
Common variants conferring risk of schizophrenia. Nature. 2009 Aug 06; 460(7256):744-7. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Børglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Böttcher Y, Olesen J, Breuer R, Möller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Réthelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Genetic Risk and Outcome in Psychosis (GROUP), Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jönsson EG, Terenius L, Agartz I, Petursson H, Nöthen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA. PMID: 19571808; PMCID: PMC3077530.
-
Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res. 2009 Sep; 113(2-3):129-37. Baeza I, Graell M, Moreno D, Castro-Fornieles J, Parellada M, González-Pinto A, Payá B, Soutullo C, de la Serna E, Arango C. PMID: 19427172.
-
Differential role of serotonergic polymorphisms in alcohol and heroin dependence. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15; 33(4):695-700. Saiz PA, Garcia-Portilla MP, Florez G, Arango C, Corcoran P, Morales B, Bascaran MT, Alvarez C, San Narciso G, Carreño E, Alvarez V, Coto E, Bobes J. PMID: 19328219.
-
Olanzapine compared to quetiapine in adolescents with a first psychotic episode. Eur Child Adolesc Psychiatry. 2009 Jul; 18(7):418-28. Arango C, Robles O, Parellada M, Fraguas D, Ruiz-Sancho A, Medina O, Zabala A, Bombín I, Moreno D. PMID: 19198920.
-
Assessment of the increase in variability when combining volumetric data from different scanners. Hum Brain Mapp. 2009 Feb; 30(2):355-68. Reig S, Sánchez-González J, Arango C, Castro J, González-Pinto A, Ortuño F, Crespo-Facorro B, Bargalló N, Desco M. PMID: 18064586; PMCID: PMC6871184.
-
Obstetric complications as a risk factor for first psychotic episodes in childhood and adolescence. Eur Child Adolesc Psychiatry. 2009 Mar; 18(3):180-4. Moreno D, Moreno-Iñiguez M, Vigil D, Castro-Fornieles J, Ortuño F, González-Pinto A, Parellada M, Baeza I, Otero S, Graell M, Aldama A, Arango C. PMID: 19184163.
-
Attitude toward antipsychotic medication as a predictor of antipsychotic treatment discontinuation in first-episode early-onset psychosis. Rev Psiquiatr Salud Ment. 2008 Dec; 1(1):10-7. Fraguas D, Llorente C, Rapado-Castro M, Parellada M, Moreno D, Ruiz-Sancho A, Medina O, Alvarez-Segura M, de Castro MJ, Arango C. PMID: 23040428.
-
Neurological soft signs in adolescents with first episode psychosis: two-year followup. Psychiatry Res. 2008 Dec 15; 161(3):344-8. Mayoral M, Bombín I, Zabala A, Robles O, Moreno D, Parellada M, Ruiz-Sancho A, Arango C. PMID: 18990454.
-
Regional gray matter volume deficits in adolescents with first-episode psychosis. J Am Acad Child Adolesc Psychiatry. 2008 Nov; 47(11):1311-20. Janssen J, Reig S, Parellada M, Moreno D, Graell M, Fraguas D, Zabala A, Garcia Vazquez V, Desco M, Arango C. PMID: 18827723.
-
DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents. Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 05; 147B(6):873-9. Bombin I, Arango C, Mayoral M, Castro-Fornieles J, Gonzalez-Pinto A, Gonzalez-Gomez C, Moreno D, Parellada M, Baeza I, Graell M, Otero S, Saiz PA, Patiño-Garcia A. PMID: 18351593.
-
Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. J Child Adolesc Psychopharmacol. 2008 Aug; 18(4):327-36. Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M, Paya B, Moreno D, de la Serna E, Arango C. PMID: 18759642.
-
QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents. J Child Adolesc Psychopharmacol. 2008 Aug; 18(4):381-3. de Castro MJ, Fraguas D, Laita P, Moreno D, Parellada M, Pascual D, Alvarez M, Merchán-Naranjo J, Rapado M, Giráldez M, Leiva M, Arango C. PMID: 18759648.
-
A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study. Schizophr Res. 2008 Sep; 104(1-3):1-12. Arango C, Bobes J, Aranda P, Carmena R, Garcia-Garcia M, Rejas J, CLAMORS Study Collaborative Group. PMID: 18606526.
-
Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics. J Clin Psychiatry. 2008 Jul; 69(7):1166-75. Fraguas D, Merchán-Naranjo J, Laita P, Parellada M, Moreno D, Ruiz-Sancho A, Cifuentes A, Giráldez M, Arango C. PMID: 18588363.
-
[Antidepressant drugs in the treatment of tension-type headache]. Med Clin (Barc). 2008 May 24; 130(19):751-7. Medina Ortiz O, Arango C, Ezpeleta D. PMID: 18570803.
-
Longitudinal brain changes in early-onset psychosis. Schizophr Bull. 2008 Mar; 34(2):341-53. Arango C, Moreno C, Martínez S, Parellada M, Desco M, Moreno D, Fraguas D, Gogtay N, James A, Rapoport J. PMID: 18234701; PMCID: PMC2632400.
-
Progression of brain volume changes in adolescent-onset psychosis. Schizophr Bull. 2009 Jan; 35(1):233-43. Reig S, Moreno C, Moreno D, Burdalo M, Janssen J, Parellada M, Zabala A, Desco M, Arango C. PMID: 18222929; PMCID: PMC2643965.
-
Progressive brain changes in schizophrenia. Schizophr Bull. 2008 Mar; 34(2):310-1. Arango C, Kahn R. PMID: 18212323; PMCID: PMC2632394.
-
Patterns of cranial, brain and sulcal CSF volumes in male and female deficit and nondeficit patients with schizophrenia. Psychiatry Res. 2008 Feb 28; 162(2):91-100. Arango C, McMahon RP, Lefkowitz DM, Pearlson G, Kirkpatrick B, Buchanan RW. PMID: 18201875.
-
Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrum. Biol Psychiatry. 2008 Mar 01; 63(5):498-504. Robles O, Blaxton T, Adami H, Arango C, Thaker G, Gold J. PMID: 17916332; PMCID: PMC2701547.
-
Psychopathological sequelae of the 11 March terrorist attacks in Madrid : an epidemiological study of victims treated in a hospital. Eur Arch Psychiatry Clin Neurosci. 2008 Feb; 258(1):28-34. Conejo-Galindo J, Medina O, Fraguas D, Terán S, Sainz-Cortón E, Arango C. PMID: 17901996.
-
Is attempted suicide different in adolescent and adults? Psychiatry Res. 2008 Jan 15; 157(1-3):131-7. Parellada M, Saiz P, Moreno D, Vidal J, Llorente C, Alvarez M, García-Portilla P, Ruiz-Sancho A, Arango C, Bobes J. PMID: 17888518.
-
Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis. Psychiatry Res. 2007 Oct 15; 156(1):33-42. Zabala A, Sánchez-González J, Parellada M, Moreno DM, Reig S, Burdalo MT, Robles O, Desco M, Arango C. PMID: 17764911.
-
Antipsychotic-related abnormal involuntary movements and metabolic and endocrine side effects in children and adolescents. J Child Adolesc Psychopharmacol. 2007 Aug; 17(4):487-502. Laita P, Cifuentes A, Doll A, Llorente C, Cortés I, Parellada M, Moreno D, Ruiz-Sancho A, Graell M, Arango C. PMID: 17822343.
-
Does diagnostic classification of early-onset psychosis change over follow-up? Child Psychiatry Hum Dev. 2008 Jun; 39(2):137-45. Fraguas D, de Castro MJ, Medina O, Parellada M, Moreno D, Graell M, Merchán-Naranjo J, Arango C. PMID: 17665305.
-
The child and adolescent first-episode psychosis study (CAFEPS): design and baseline results. Schizophr Res. 2007 Mar; 91(1-3):226-37. Castro-Fornieles J, Parellada M, Gonzalez-Pinto A, Moreno D, Graell M, Baeza I, Otero S, Soutullo CA, Crespo-Facorro B, Ruiz-Sancho A, Desco M, Rojas-Corrales O, Patiño A, Carrasco-Marin E, Arango C, CAFEPS group. PMID: 17267179.
-
Neurological soft signs in adolescents with first episode psychosis. Eur Psychiatry. 2006 Jul; 21(5):283-7. Zabala A, Robles O, Parellada M, Moreno DM, Ruiz-Sancho A, Burdalo M, Medina O, Arango C. PMID: 16360308.
-
Structural neuroimaging in adolescents with a first psychotic episode. J Am Acad Child Adolesc Psychiatry. 2005 Nov; 44(11):1151-7. Moreno D, Burdalo M, Reig S, Parellada M, Zabala A, Desco M, Baca-Baldomero E, Arango C. PMID: 16239864.
-
The effect of quetiapine on aggression and hostility in patients with schizophrenia. Hum Psychopharmacol. 2005 Jun; 20(4):237-41. Arango C, Bernardo M. PMID: 15830402.
-
Clinical effectiveness of new generation antipsychotics in adolescent patients. Eur Neuropsychopharmacol. 2004 Nov; 14 Suppl 4:S471-9. Arango C, Parellada M, Moreno DM. PMID: 15572266.
-
The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms. Eur Psychiatry. 2004 Feb; 19(1):21-6. Arango C, Buchanan RW, Kirkpatrick B, Carpenter WT. PMID: 14969777.
-
Morphometric assessment of the heteromodal association cortex in schizophrenia. Am J Psychiatry. 2004 Feb; 161(2):322-31. Buchanan RW, Francis A, Arango C, Miller K, Lefkowitz DM, McMahon RP, Barta PE, Pearlson GD. PMID: 14754782.
-
[A brief questionnaire for the diagnosis of maladaptive behavior disorders in adolescents aged between 12 and 16 years of age]. Rev Neurol. 2000 Jun 16-30; 30(12):1145-50. Pineda DA, Puerta IC, Arango CP, Calad OM, Villa MT. PMID: 10935240.
US